2023 Annual Report
Aehr Test Systems
Delivering Turnkey Production Test and Burn-in
Solutions for Semiconductors Where Quality,
Reliability, Safety or Security are
Absolutely Critical.
FINANCIAL HIGHLIGHTS
PRODUCTS
Aehr Test Systems provides turnkey solutions used in a wide range of test and reliability screening (burn-in)
applications for high reliability semiconductors used in many applications including electric vehicles and
electric vehicle charging infrastructure, automotive applications, mobile devices, computing, solid state
memory storage, networking and data storage, and telecommunications including 5G infrastructure. The
turnkey solutions include test and burn in systems, consumable contactors between the test systems and the
devices under test in wafer, singulated die, package and module form, and devices handlers and aligners that
manually or automatically move the devices under test into position to make contact with the consumable
contactors. Test systems include both wafer and singulated die and module systems within the FOX-P Family
of test and burn-in systems, and the Automated Burn-in and Test System (ABTS) family of packaged part test
and burn-in systems.
The FOXTM-XP Test and Burn-in System is designed for
single-touchdown testing of up to 18 wafers at a time and for
testing singulated die or small modules. The FOX-NP is a
low-cost entry-level system to provide a configuration and
price point for companies to do initial production
qualification and new product introduction, enabling an easier
transition to the FOX-XP system for high volume production
test. The FOX-XP and FOX-NP systems are optimized for
test and burn-in where the test time is measured in hours or
days and the full wafer can be tested in a single touchdown.
Both systems are capable of testing wafers with thousands of
devices in a single touchdown using Aehr Test’s proprietary
WaferPak full wafer contactors.
FOX-NP and FOX-XP Wafer
Level Test & Burn-in Systems
(in thousands, except per share data) For the years ended May 31, 2023 2022 2021 Net sales $64,961 $50,829 $16,600 Income (loss) from operations 13,375 7,800 (4,182) Net income (loss) 14,557 9,450 (2,027) Earnings (net loss) per share - diluted 0.50 0.34 (0.09) Cash and cash equivalents 30,054 31,484 4,582 Working capital 72,722 48,993 10,123 Shareholders’ equity 75,600 50,989 11,449 PRODUCTS
The FOX-CP is a low-cost single-wafer compact test burn-in
solution that is integrated with an automated single wafer
prober for applications where test times range from only a few
minutes to a few hours or where multiple touchdowns are
required to test the entire wafer.
The FOX-1P Full Wafer Parallel Test System is designed for
massively parallel testing in wafer sort. By utilizing Design for
Testability (DFT) or Built-In Self-Test (BIST), test costs can be
decreased significantly due to the extremely high parallelism of
the system. It can be configured to dock to a single wafer
prober or dual wafer probers such as shown in the photo to the
right.
Aehr Test’s patented WaferPak Contactor and DiePak®
Carriers connect electrical and optical test resources from
Aehr’s FOX systems to the customer’s wafer or singulated
die/modules to be tested or burned-in. Both products contain
micro-miniature probes to contact all the die/modules in a
single insertion.
Full wafer contact of all the devices on a wafer is made feasible
using Aehr’s proprietary WaferPaks and WaferPak Aligners.
Aehr provides fully Automated Aligners for hands free
operation while docked to multi-wafer FOX-XP ’s or can be
used “offline” to allow WaferPak Alignment to serve multiple
FOX-XPs in production. Aehr also provides a low-cost
Aligner for use in engineering and low volume production
applications.
FOX-CP and FOX-1P Wafer
Level Test & Burn-in Systems
FOX Automated WaferPak Aligner
Docked to an 18 Wafer FOX-XP
Automated Burn-in and Test System (ABTS) family of packaged part test
and burn-in systems are used for traditional package part reliability
qualification and also for production burn-in of devices where their
extrinsic or early failure rate is not acceptable to the end application. The
ABTS system uses device package burn-in boards test devise in packaged
form whereas the FOX systems used Aehr proprietary WaferPak full
wafer contactors or DiePak singulated die or module carriers to test and
burn-in devices in wafer or singulated die / module form to remove early
failures and to lower the failure rate to address applications where quality,
reliability, safety or security are absolutely critical.
ABTS Test & Burn-in System
This Annual Report contains certain “forward-looking” statements based on current expectations, forecasts and assumptions that involve risks and
uncertainties. Forward-looking statements include statements relating to future market opportunities and conditions, industry growth and customer
demand for Aehr Test's products. Actual results may differ materially from those stated or implied due to risks and uncertainties. See Aehr Test's recent
10-K report that is part of this Annual Report for a more detailed description of the risks facing our business. Aehr Test disclaims any obligation to
update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this Annual Report.
L
E
T
T
E
R
T
O
O
U
R
S
H
A
R
E
H
O
L
D
E
R
S
Dear Shareholders, Customers, Partners, and Employees,
Fiscal 2023 was a breakout year for Aehr Test Systems. We achieved record financial performance for the full
fiscal year. We significantly expanded our customer base with additional silicon carbide customers and saw
increasing momentum with our benchmarks and engagements with prospective new customers. We
successfully introduced several significant new test system enhancements that broadened our total available
market and extended the competitive advantage of our FOXTM products. We see new market opportunities on
the horizon that we believe can become significant additional markets for our differentiated and proprietary
wafer-level test and burn-in products.
We finished fiscal 2023 with record financial performance, including record annual revenue, bookings
and profit. For the fiscal year, total revenue grew 28% to $65.0 million, our highest annual revenue on record.
We also generated record bookings for the year of $78.3 million. With our higher revenue, we saw significant
leverage in our operating model. We also recorded record GAAP and non-GAAP profit of $14.6 million and
$17.3 million, respectively. This represents year-over-year growth of 54% and 62%, respectively. We generated
a record $10 million in operating cash flow, up more than 500% from the prior year, and we finished the year
with a strong balance sheet, with nearly $48 million in cash and short-term investments and no debt.
Our record performance was driven by demand for our FOX solutions for silicon carbide
semiconductors used in electric vehicles and electric vehicle charging infrastructure, as well as silicon
photonics devices used in data and telecommunications infrastructure and a new application for multi-chip
modules using optical data interconnections. Semiconductor companies are adding significant capacity to
manufacture silicon carbide semiconductors to address forecasted demand, particularly for the electric vehicle
and electric vehicle charger markets. The silicon carbide market for electric vehicles and its supporting
infrastructure requirements are growing at a tremendous rate, with industry data suggesting a compound annual
growth rate (CAGR) of close to 50% over the rest of this decade. Our unique wafer-level test and burn-in
products provide complete solutions for semiconductor manufacturers for high-volume test, burn-in, and
stabilization of semiconductors such as those used in electric vehicles, electric vehicle charging infrastructure,
photovoltaic (solar) power conversion, and data and telecommunications infrastructure.
William Blair forecasts total demand for silicon carbide wafers just for electric vehicles (including electric
vehicle inverters and on-board and off-board chargers) to grow from 220,000 wafers in 2022 to over 4.5
million 6-inch equivalent wafers in 2030, a greater than 45% CAGR and over 20 times larger in 2030 than in
2022.
In addition, they expect demand for industrial applications, electric trains, energy conversion, and radio
frequency amplifiers to drive another 2.8 million silicon carbide wafers in 2030. This further expands the total
available silicon carbide test and burn-in market.
We significantly expanded our customer base with the addition of four new silicon carbide customers
this past year, and we expect to add more in fiscal 2024. Each of these new customers is already ramping
or is planning to ramp our products into high-volume production using our multi-wafer test and burn-in
systems. These new customers, which include another one of the top four silicon carbide market participants,
expand our market penetration beyond our initial lead silicon carbide wafer-level burn-in customer and provide
us with confidence in our ability to gain significant market share of the test and burn-in market for silicon
carbide devices.
Our benchmarks and engagements with prospective new silicon carbide customers are increasing and
making great progress. With essentially all Covid-related restrictions behind us throughout the world, our
customer-facing meetings and our progress on new customer opportunities have grown substantially. Our
increasing engagements with numerous potential customers give us confidence in our growth expectations over
the next several years, particularly as the positive momentum in demand for silicon carbide in electric vehicles
continues to accelerate.
We continue to engage with current suppliers of silicon carbide devices as well as companies planning to enter
into this market. We are working closely with one of the largest silicon carbide players in the world on a large
wafer-level benchmark and qualification for automotive and other markets. This qualification continues to
make great progress and we believe this will ultimately result in them moving to our FOX solution for their
volume production.
While the majority of the silicon carbide applications driving our wafer-level burn-in capacity to date have been
purchased for electric vehicles and electric vehicle charging infrastructures, we are also seeing high levels of
interest for our solutions to test and burn-in silicon carbide in other markets including solar, wind, and
numerous industrial applications.
In addition to our momentum in silicon carbide, we are seeing increasing interest in our products
for the emerging market for gallium nitride devices. We have multiple potential new customers inquiring
about our systems to test and burn-in gallium nitride semiconductors. Similar to silicon carbide, gallium nitride
is also a wide band-gap compound semiconductor being applied for efficient high-speed power conversion
applications. While silicon carbide devices and modules have key advantages for the very high-power traction
inverters and onboard and offboard chargers for electric vehicles and other high-power industrial applications,
gallium nitride is generally believed to be superior for lower-power applications, particularly under 1,000 watts.
We believe gallium nitride will be a significant market, driven by high-volume applications such as electronic
power converters in data centers, solar power inverters, and power and conversion applications in standard and
electric vehicles. Both silicon carbide and gallium nitride device types are forecasted to grow significantly over
the next several years and into the future.
The gallium nitride market appears to be a potentially significant growth driver for our systems and
WaferPakTM full-wafer Contactors, particularly for automotive and photovoltaic applications where burn-in
appears to be critical for meeting the initial quality and reliability needs of those markets. With the proven cost-
effective ability of our FOX-XP wafer-level burn-in solution to test thousands of devices in parallel and up to
nine wafers at a time, we believe we are well positioned to capitalize on this opportunity and believe that
gallium nitride can expand our total addressable market in a meaningful way.
We saw a strong recovery in the silicon photonics market and also see a major market opportunity
with the upcoming application of silicon photonics integrated circuits for use in optical chip-to-chip
communication. Following the weakness we saw during the pandemic, full year revenue from our shipments
to silicon photonics customers this past year was up more than 45% year over year. This jump in revenue was
also spread across multiple customers with much of it for new product designs and qualifications that we
believe will lead to production volumes. We continue to be very enthusiastic about the current market for
silicon photonics devices used in data communication, which combines electrical semiconductor integrated
circuits with photonics or light-based transmitters and receivers.
We see the potential to integrate photonics integrated circuit devices into multi-chip modules as a major new
market opportunity for Aehr. Multiple large semiconductor suppliers such as Intel, AMD, Nvidia, TSMC and
GlobalFoundries have publicly discussed roadmaps to integrate optical devices into processors in what are
being referred to as optical input/output (I/O) and co-packaged optics devices for markets such as data
servers, computing, and Artificial Intelligence (AI). This new potential market is in addition to the current
transceiver market for data and telecommunications.
Late in the year, we received our first order from a major silicon photonics customer for a new high-power
configuration of our FOX-XP system for production wafer-level burn-in of next-generation silicon photonic-
based integrated circuits, which can require up to two to four times as much power for full-wafer test, burn-in,
and stabilization. This customer is one of the world’s largest semiconductor manufacturers and we expect to
receive orders for additional production systems as they increase production of these devices. The testing
ability of this new FOX production system configuration for new high-power density devices, which can be
used in new optical I/O or heterogeneous integrated packages, is unprecedented in the industry and expands
the market opportunities of the FOX-XP system even further.
We are beginning to see the front end of this opportunity and Aehr currently already has six customers
including the market leader that have adopted our FOX-XP and NP systems for production burn-in of their
silicon photonics devices. While we believe this new optical I/O market is still several years out before it
reaches volume production, we feel the silicon photonics test and burn-in market can become significant and
could grow to be as large or even larger than the silicon carbide market later in this decade.
We introduced several significant test system enhancements that extend the market leadership of our
FOX products for full-wafer test and burn-in and open new markets. Both silicon carbide and gallium
nitride semiconductors address the high-voltage power semiconductor markets that are significant
opportunities for our FOX wafer-level test and burn-in systems and WaferPak full-wafer Contactors. As we
look to further penetrate these markets, we continue to add new capabilities to our wafer-level test and burn-in
systems to address these new markets. These include the FOX Bipolar Voltage Channel Module (BVCM) and
Very High Voltage Channel Module (VHVCM) options, which enable new advanced test and burn-in
capabilities for silicon carbide and gallium nitride power semiconductors on Aehr’s FOX-P wafer-level test and
burn-in systems.
During the fiscal year we also completed a multi-year development and began shipments to customers of our
new fully automated FOX WaferPak Aligner, which enables hands-free operation of WaferPak handling and
alignment and is available either as a stand-alone or in full integration with our FOX-XP system. As capacity
and volume forecasts increase, eliminating all manual interfaces for automated handling can become critical to
our customers. The added automation capability of our new Aligner gives our wafer-level test and burn-in
offering even greater value and opens several incremental markets to Aehr, such as high-volume processors
and chipsets with integrated photonics transceivers, flash and ultimately DRAM memories.
Each of these product enhancements broadens our total available market and extends our cost competitiveness
and application space for our FOX products, and we continue to invest to enhance our existing market-leading
products and to introduce new products to maintain our competitive advantages and to expand our
applications in addressable markets.
As we move into fiscal 2024, we have a significant competitive product advantage and are well
positioned for significant growth. Our customers use our products to test, burn-in, and stabilize
semiconductors used for applications where safety, security, quality, and reliability are absolutely critical,
including electric vehicles, electric vehicle chargers, photovoltaic or solar, power conversion, industrial, and
data and telecommunications applications.
With the unprecedented unique capabilities and cost-effectiveness of our FOX-P platform, we have highly
differentiated solutions for full wafer-level test and burn-in that put us in an excellent position to continue to
gain significant market share of these new and growing market opportunities.
The market forecast for wafer-level burn-in products is significant. William Blair estimates that the total
available market for wafer-level burn-in products for silicon carbide alone will be over $400 million by
2027. We believe Aehr has the potential to capture a significant portion of that market based on the level of
silicon carbide engagements we have with customers across the globe. With the continued positive momentum
that we are seeing with our current and prospective customers and the expanding growth opportunities from
emerging markets, we are confident in our expectation for significant growth in the coming year.
I continue to be grateful to our employees, customers, partners and shareholders for their support.
Gayn Erickson, President and CEO
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-K
(Mark One)
Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the fiscal year ended May 31, 2023
or
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ________________ to ________________
Commission file number: 000-22893.
AEHR TEST SYSTEMS
(Exact name of registrant as specified in its charter)
CALIFORNIA
(State or other jurisdiction of
incorporation or organization)
94-2424084
(IRS Employer Identification Number)
400 KATO TERRACE, FREMONT, CA
(Address of principal executive offices)
94539
(Zip Code)
Registrant’s telephone number, including area code: (510) 623-9400
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Common Stock,
par value $0.01 per share
Trading
Symbol(s) Name of each exchange on which registered
AEHR
The NASDAQ Capital Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the
Securities Act. Yes No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for
such shorter period that the registrant was required to submit such files). Yes No
1
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”
“accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer
Non-accelerated filer
Emerging growth company
Accelerated filer
Smaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act.
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of
the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15
U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial
statements of the registrant included in the filing reflect the correction of an error to previously issued financial
statements. Yes No
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of
incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period
pursuant to §240.10D-1(b). Yes No
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
The aggregate market value of the registrant’s common stock, par value $0.01 per share, held by non-affiliates of the
registrant, based upon the closing price of $26.07 on November 30, 2022, as reported on the NASDAQ Capital Market,
was $663,547,666. For purposes of this disclosure, shares of common stock held by persons who hold more than 5% of
the outstanding shares of common stock (other than such persons of whom the Registrant became aware only through
the filing of a Schedule 13G filed with the Securities and Exchange Commission) and shares held by officers and
directors of the Registrant have been excluded because such persons may be deemed to be affiliates. This determination
of affiliate status is not necessarily conclusive for other purposes.
The number of shares of registrant’s common stock, par value $0.01 per share, outstanding at July 31, 2023 was
28,755,426.
DOCUMENTS INCORPORATED BY REFERENCE:
Portions of registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders are incorporated
by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be
filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended
May 31, 2023.
2
AEHR TEST SYSTEMS
FORM 10-K
FISCAL YEAR ENDED MAY 31, 2023
TABLE OF CONTENTS
PART I
Item 1.
Business ................................................................................................................................................................... 4
Item 1A. Risk Factors .......................................................................................................................................................... 11
Item 1B. Unresolved Staff Comments ............................................................................................................................. 18
Properties .............................................................................................................................................................. 18
Item 2.
Legal Proceedings ................................................................................................................................................ 18
Item 3.
Mine Safety Disclosures ..................................................................................................................................... 18
Item 4.
PART II
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities .................................................................................................................... 18
[Reserved] ............................................................................................................................................................. 19
Item 6.
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations ................ 19
Item 7A. Quantitative and Qualitative Disclosures about Market Risk ..................................................................... 25
Financial Statements and Supplementary Data .............................................................................................. 26
Item 8.
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure ............... 54
Item 9A. Controls and Procedures .................................................................................................................................... 54
Item 9B. Other Information ............................................................................................................................................. 54
Item 9C. Disclosure Regarding Foreign Jurisdiction that Prevent Inspections ........................................................ 54
PART III
Item 10. Directors, Executive Officers and Corporate Governance ......................................................................... 55
Executive Compensation ................................................................................................................................... 55
Item 11.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
Item 12.
Item 13.
Item 14.
Matters ............................................................................................................................................................ 55
Certain Relationships and Related Transactions, and Director Independence ........................................ 55
Principal Accountant Fees and Services .......................................................................................................... 55
Item 15.
Item 16.
Exhibits and Financial Statement Schedules .................................................................................................. 56
Form 10-K Summary .......................................................................................................................................... 59
PART IV
Signatures .............................................................................................................................................................. 60
3
This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Section 27A of
the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as
amended (the Exchange Act). All statements contained in this Annual Report on Form 10-K other than statements of
historical fact, including statements regarding our future results of operations and financial position, our business
strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,”
“may,” “will,” “estimate,” “continue,” “anticipate,” “plan,” “intend,” “expect,” “could,” “target,” “project,” “should,”
“predict,” “potential,” “would,” “seek” and similar expressions and the negative of those expressions are intended to
identify forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties
and assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those
expressed in any forward-looking statements. These risks include but are not limited to those factors identified in “Risk
Factors” beginning on page 11 of this Annual Report on Form 10-K, those factors that we may from time to time
identify in our periodic filings with the Securities and Exchange Commission, as well as other factors beyond our
control. We undertake no obligation to revise or update publicly any forward-looking statements for any reason. Unless
the context requires otherwise, references in this Form 10-K to “Aehr Test,” the “Company,” “we,” “us” and “our”
refer to Aehr Test Systems.
Investors and others should note that we announce material financial information to our investors using our investor
relations website (https://www.aehr.com/investor-relations/), SEC filings, press releases, public conference calls and
webcasts. We use these channels to communicate with our investors and the public about our company, our products
and services and other issues. It is possible that the information we post on our investor relations website could be
deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company
to review the information we post on our investor relations website.
PART I
Item 1.
Business
THE COMPANY
Aehr Test Systems, Inc. (“Aehr Test,” “Aehr,” or “we”) was incorporated in the state of California on May 25, 1977
and is headquartered in Fremont, California. We are a leading provider of test solutions for testing, burning-in, and
stabilizing semiconductor devices in wafer level, singulated die, and package part form, and have installed thousands of
systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple
applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, data
and telecommunications infrastructure, and solid-state memory storage, are driving additional test requirements,
incremental capacity needs, and new opportunities for Aehr Test products and solutions. We have developed and
introduced several innovative products including the FOX-PTM family of test and burn-in systems and FOX
WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and
FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and
stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D
sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors,
microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost
single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P
product family. The FOX WaferPak Contactor contains a unique full wafer contactor capable of testing wafers up to
300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems.
The FOX DiePak Carrier allows testing, burn-in, and stabilization of singulated bare die and modules up to 1,024
devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time.
INDUSTRY BACKGROUND
Semiconductor manufacturing is a complex, multi-step process, and defects or weaknesses that may result in the
failure of a semiconductor device may be introduced at any process step. Failures may occur immediately or at any time
during the operating life of the device, sometimes after several months of normal use. Semiconductor manufacturers
rely on testing and reliability screening to identify and eliminate defects that occur during the manufacturing process.
Testing and reliability screening involve multiple steps. The first set of tests is typically performed by semiconductor
device manufacturers before the processed semiconductor wafer is cut into individual die, in order to avoid the cost of
packaging defective die into their packages. This “wafer probe” testing can be performed on one or many die at a time,
including testing the entire wafer at once. Most leading-edge microprocessors, microcontrollers, digital signal
processors, memory ICs, sensors, power and optical devices (such as vertical-cavity surface-emitting lasers, or VCSELs)
then undergo an extensive reliability screening and stress testing procedure known as burn-in or cycling, depending on
the application. This can either be done at the wafer level, before the die are packaged, or at the package level, after the
die are packaged. The burn-in process screens for early failures by operating the device at elevated voltages and
4
temperatures, at up to 150 degrees Celsius (302 degrees Fahrenheit) or higher. Depending upon the application, the
burn-in times can range anywhere from minutes to hours or even days. A typical burn-in system can process thousands
of devices simultaneously. After burn-in, the devices undergo a final test process using automatic test equipment, or
testers. For example, this cycling process screens silicon carbide semiconductor devices used in electric vehicle engine
controller inverters and their corresponding on-board battery chargers for failure to meet current carrying, power loss
and leakage specifications, as well as endurance requirements.
MARKETS
The Company’s semiconductor test and reliability qualification solutions address multiple test and burn-in markets
including Silicon Carbide (SiC) and Gallium Nitride (GaN) devices for power semiconductors, electric vehicles, electric
vehicle charging infrastructure, solar and wind power, silicon photonics for data center infrastructure and worldwide 5G
infrastructure, 2D/3D sensors for consumer electronics and automotive applications, and the data storage and memory
markets.
Power Semiconductors (Silicon Carbide and Gallium Nitride)
Silicon carbide power semiconductors have emerged as the preferred technology for battery electric vehicle power
conversion in on-board and off-board electric vehicle battery chargers, and the electric power conversion and control of
the electric engines. These devices reduce power loss by as much as greater than 75% over power silicon alternatives like
IGBT (Insulated-Gate Bipolar Transistor) devices, which has essentially changed the entire market dynamic. With this
development, the Company sees most, if not every automotive company that is working on electric vehicles, moving to
silicon carbide-based powertrain and charging systems in the near future.
The gallium nitride market appears to be a potentially significant growth driver for our systems and WaferPak full
wafer Contactors, particularly for automotive and photovoltaic applications where burn-in appears to be critical for
meeting the initial quality and reliability needs of those markets.
The Company’s FOX-P family of products are very cost-effective solutions for ensuring the critical quality and
reliability of devices in this market, where performance and reliability can not only mean increased battery life, but also
assurance against failure of a vehicle whose power semiconductor fails in the power train.
Silicon Photonics
The silicon photonics market is seeing increasing deployment of devices used in the expansion of bandwidth and
infrastructure to meet the explosive growth of data center and 5G infrastructure.
The rapid growth of integrated optical devices in data centers and data center interconnect infrastructure, mobile
devices, automotive applications, and wearable biosensor markets is driving substantially higher requirements for initial
quality and long-term reliability, and they are increasing with every new product generation. The upcoming application of
silicon photonics integrated circuits for use in optical chip-to-chip communication in addition to the current photonics
as multiple companies have made announcements regarding their product roadmaps for co-packaged photonics
integrated circuits with microprocessors, graphics processors, chip sets for computing as well as artificial intelligence
applications.
Silicon photonics devices are highly integrated silicon-based semiconductors that have embedded or integrated the
non-silicon-based laser transmitters and receivers to enable a smaller, lower cost, higher reliable alternative to traditional
fiber optic transceivers currently used in data center and telecommunication infrastructure. These require a process step
in manufacturing called stabilization where the devices are subjected to high temperatures and power to stabilize their
output power. The Company’s solution makes it feasible to burn-in integrated silicon photonics devices while still in
wafer form without adding the cost to the transceiver printed circuit board and other mechanical infrastructure of the
final transceiver module, and that has both yield and significant cost savings. In the case of silicon photonics, the laser
devices are bonded directly to a silicon-based device that has all the logic multiplexing and de-multiplexing, and other
high-speed communication subsystems, all integrated into a silicon-based integrated circuit.
Mobile 2D and 3D Sensors
Sensors used in mobile devices such as smartphones, tablets, wearables such as watches and fitness bands, and audio
devices have become pervasive. Initially, sensors on smartphones allowed basic functions we have all come to expect
such as touchscreens, rotational sensors, and fingerprint sensors, but have gotten more complex with added capabilities
such as 3D facial recognition and time of flight distance measurements. We will see the addition of health monitoring
sensors, 3D measurement capability, and other advanced sensors in the future. As sensors become more pervasive and
add critical new functionality to devices, it becomes more and more important that the data collected be accurate and
5
reliable, which we believe will drive more and more requirements for our solutions for production test and burn-in of
these sensors.
Automotive Semiconductors
In addition, the rapid growth and increasing demand for reliability in automotive sensor technologies is a key market
driver for the Company. These technologies include ADAS (Advanced Driver Assistance Systems) capabilities such as
collision avoidance systems using laser, LIDAR (Light Detection and Ranging), and RADAR (Radio Detection and
Ranging) or other sensing technologies. More and more new vehicles now include as standard capabilities collision
avoidance systems that detect obstacles and monitor the vehicle’s surroundings to notify the driver of dangerous
conditions and take evasive action. In addition to autonomous vehicles that require extremely high reliability of the
devices in these systems, more and more vehicles around the world are embedding these systems and sensors into their
everyday driving features. The Company sees the rising tide of the increasing number of embedded sensors and electrical
and optical systems in vehicles as a key driver of the increasing market need for more and more reliable semiconductors.
This, in turn, is increasing the need for 100% production test and burn-in of devices in order to lower the infant
mortality rate of devices and ensure that these devices and systems operate over the life of the vehicles.
Data Storage and Memory
The Company also sees the data storage and memory markets as critical new opportunities for its systems where
these end markets and customers require devices to have extremely high levels of quality and long-term reliability.
PRODUCTS
The Company manufactures and markets full wafer contact test systems, test during burn-in systems, test fixtures
and related accessories.
All of the Company’s systems are platform-based systems with a portfolio of current, voltage, digital and thermal
capabilities, allowing them to be configured with optional features to meet customer requirements. Systems can be
configured for use in production applications, where capacity, throughput and price are most important, or for reliability
engineering and quality assurance applications, where performance and flexibility, such as extended temperature ranges,
are essential.
FULL WAFER CONTACT SYSTEMS
Aehr’s FOX-XP test and burn-in platform allows for one of the key reliability screening tests to be completed on an
entire wafer full of devices, testing all of them at one time, while also testing and monitoring every device for failures
during the burn-in process to provide critical information on those devices. This is an enormously valuable capability, as
it allows its customers to screen devices that would otherwise fail after they are packaged into multi-die modules where
the yield impact is 10 times or even 100 times as costly.
The FOX-XP test and burn-in system, introduced in July 2016, is designed for devices in wafer, singulated die, and
module form that require test and burn-in times typically measured in hours to days. The FOX-XP system can test and
burn-in up to 18 wafers at a time. For high reliability applications, such as automotive, mobile devices, networking,
telecommunications, sensors, power and solid-state devices, the FOX-XP system is a cost-effective solution for
producing tested and burned-in die for use in multi-chip packages. Using Known-Good Die, or KGD, which are fully
burned-in and tested die, in multi-chip/heterogeneous packages helps assure the reliability of the final product and
lowers costs by increasing the yield of high-cost multi-chip packages. Wafer-level burn-in and test enables lower cost
production of KGD for multi-chip modules, 3-D stacked packages and systems-in-a-package. The FOX-XP platform
has been extended for burn-in and test of small multi-die modules by using DiePak Carriers. The DiePak Carrier with
its multi-module sockets and high wattage dissipation capabilities has a capacity of hundreds of die or modules, much
higher than the capacity of a traditional burn-in system with traditional single-device sockets and heat sinks. This
capability was introduced in March 2017.
The FOX-NP was introduced in January 2019 and is a low-cost entry-level system to provide a configuration and
price point for companies to initiate a new product introduction and production qualification, enabling an easier
transition to the FOX-XP system for high volume production test. The FOX-NP system is 100% compatible with the
FOX-XP system and is configurable with up to two slot assemblies per system compared to up to 18 slot assemblies in
the FOX-XP system.
The FOX-CP was introduced in February 2019 and is a low-cost single-wafer compact test and reliability verification
solution for logic, memory, power and photonic devices. The FOX-CP reduces test cost by functionally testing wafers
during reliability screening to identify failing logic, memory, power or photonic die before the die are integrated into
6
their final package, and is optimal for test times ranging from minutes to a few hours or where multiple touchdowns are
required to test the entire wafer. The FOX-CP includes an integrated prober which is equipped with optics for automatic
pattern recognition so that the wafer is aligned properly for the testing process. It complements the capabilities of the
FOX-XP and FOX-NP systems, which are optimal when the test time is measured in hours or days and the full wafer
can be tested in a single touchdown.
One of the key components of the FOX systems is the patented WaferPak Contactor. The WaferPak Contactor
contains a full-wafer single-touchdown probe card which is easily removable from the system. Traditional probe cards
often are only able to contact a portion of the wafer, requiring multiple touchdowns to test the entire wafer. Traditional
probe cards also require the use of a dedicated wafer prober handler for each wafer in order to press the wafer up to
make contact with the probe card. The need for a wafer prober per wafer is a significant cost adder to the cost of testing
a wafer, and also creates the need for significant clean room space to facilitate the footprint of a wafer prober per wafer.
The unique design of the WaferPak as well as the FOX-XP and FOX-NP systems remove the need for a dedicated
wafer prober per wafer, allowing for better utilization of clean room space. A single FOX-XP system with a set of
WaferPak Contactors can test up to 18 wafers at a time in the same footprint as a single-wafer wafer prober and test
system offered by Aehr’s competitors. The WaferPak Contactor is intended to accommodate a wide range of contactor
technologies so that the contactor technology can evolve along with the changing requirements of the customer’s wafers.
The WaferPak Contactors are custom designed for each device type, each of which has a typical lifetime of two to seven
years, depending on the device life cycle. Therefore, multiple sets of WaferPak Contactors could be purchased over the
life of a FOX system.
Another key component of the FOX-XP and FOX-NP systems is the patented DiePak Carrier. The DiePak Carrier,
which is easily removable from the system, contains many multi-module or die sockets with very fine-pitch probes.
Traditional sockets contact only a single device, requiring multiple large numbers of sockets and burn-in boards to test a
production lot of devices. The unique design accommodates a wide range of socket sizes and densities so that the
DiePak Carrier technology can evolve along with the changing requirements of the customer’s devices. The DiePak
Carriers are custom designed for each device type, each of which has a typical lifetime of two to seven years, depending
on the device life cycle. Therefore, multiple sets of DiePak Carriers could be purchased over the life of a FOX-XP or
FOX-NP system.
Another key component of our FOX-XP and FOX-NP and test solution is the WaferPak Aligner. The WaferPak
Aligner performs alignment of the customer’s wafer to the WaferPak Contactor so that the wafer can be tested and
burned-in by the FOX-XP and FOX-NP systems. The Company offers an automated aligner for high volume
production applications, which can support several FOX-XP or FOX-NP systems or can be connected to a FOX-XP
resulting in a fully integrated automated test cell, and a manual aligner for low volume production or engineering
applications. The latest generation Automated WaferPak Aligner supports industry standard Automated Material
Handling System (AMHS), Automated Guided Vehicle (AGV), Overhead Hoist Transfer (OHT) and SEMI Equipment
Communication Standard (SECS) and Generic Equipment Mode (GEM) Semi E84 factory integration enabling “Lights-
out” fully automated wafer handling. Supporting a wide range of wafer sizes (e.g. 100/200/300mm) allows a broad
range of customers to implement fully automated wafer level test and burn-in factories.
Similar to the WaferPak Aligner for WaferPak Contactors, the Company offers the DiePak Loader for DiePak
Carriers. The DiePak Loader performs automatic loading of the customer’s modules to the DiePak Carrier so that the
modules can be tested and burned-in by the FOX-XP and FOX-NP system. Typically, one DiePak Loader can support
several FOX-XP or FOX-NP systems.
Net sales of full wafer contact product lines, systems, WaferPak Contactors, DiePaks Carriers and services for fiscal
2023, 2022 and 2021 were $63.5 million, $48.9 million, and $15.0 million, respectively, and accounted for approximately
98%, 96% and 90% of the Company’s net sales in fiscal 2023, 2022 and 2021, respectively.
SYSTEMS FOR PACKAGED PARTS
Test during burn-in, or TDBI, systems consist of several subsystems: pattern generation and test electronics, control
software, network interface and environmental chamber. The test pattern generator allows duplication of most of the
functional tests performed by a traditional tester. Pin electronics at each burn-in board, or BIB, position are designed to
provide accurate signals to the ICs being tested and detect whether a device is failing the test.
Devices being tested are placed on BIBs and loaded into environmental chambers which typically operate at
temperatures from 25 degrees Celsius (77 degrees Fahrenheit) up to 150 degrees Celsius (302 degrees Fahrenheit). Using
our optional chambers, our systems can produce temperatures as low as -55 degrees Celsius (-67 degrees Fahrenheit). A
single BIB can hold up to several hundred ICs, and a production chamber holds up to 72 BIBs, resulting in thousands of
memory or logic devices being tested in a single system.
7
The Advanced Burn-in and Test System, or ABTS, was introduced in fiscal 2008. Several updates to the ABTS
system have been made since its introduction, including the ABTS-P system released in 2012. The ABTS family of
products is based on a hardware and software architecture that is intended to address not only today’s devices, but also
future devices for many years to come. The ABTS system can test and burn-in both high-power logic and low-power
ICs. It can be configured to provide individual device temperature control for devices up to 70W or more and with up
to 320 I/O channels. The ABTS system is nearing the end of its lifecycle and limited shipments are expected in the
future.
Net sales of packaged part product lines, systems and services for fiscal 2023, 2022 and 2021 were $1.4 million, $1.9
million, and $1.6 million, respectively, and accounted for approximately 2%, 4% and 10% of the Company’s net sales in
fiscal 2023, 2022 and 2021, respectively.
CUSTOMERS
The Company markets and sells its products throughout the world to semiconductor manufacturers, semiconductor
contract assemblers, electronics manufacturers and burn-in and test service companies.
Sales to the Company’s five largest customers accounted for approximately 97%, 98%, and 84% of its net sales in
fiscal 2023, 2022 and 2021, respectively. During fiscal 2023, two customers accounted for approximately 79% and 10%
of the Company’s net sales. During fiscal 2022, one customer accounted for approximately 82% of the Company’s net
sales. During fiscal 2021, four customers accounted for approximately 24%, 23%, 20% and 10%, respectively, of the
Company’s net sales. No other customers accounted for more than 10% of the Company’s net sales for any of these
periods. The Company expects that sales of its products to a limited number of customers will continue to account for a
high percentage of net sales for the foreseeable future. In addition, sales to particular customers may fluctuate
significantly from quarter to quarter. Such fluctuations may result in changes in utilization of the Company’s facilities
and resources. The loss of or reduction or delay in orders from a significant customer or a delay in collecting or failure
to collect accounts receivable from a significant customer could materially and adversely affect the Company’s business,
financial condition and operating results.
MARKETING, SALES AND CUSTOMER SUPPORT
The Company has sales and service operations in the United States, Germany, Philippines and Taiwan, dedicated
service resources in China and South Korea, and has established a network of distributors and sales representatives in
certain key parts of the world. See “REVENUE RECOGNITION” in Item 7 under “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” for a further discussion of the Company’s relationship with
distributors, and its effects on revenue recognition.
The Company’s customer service and support program includes system installation, system repair, applications
engineering support, spare parts inventories, customer training and documentation. The Company has applications
engineering and field service personnel located near and sometimes co-located at our customers and includes resources
at the corporate headquarters in Fremont, California, at customer locations in Texas, at the Company’s subsidiaries in
Germany and the Philippines, at its branch office in Taiwan, and also through third-party agreements in China and
South Korea. The Company’s distributors provide applications and field service support in other parts of the world.
The Company customarily provides a warranty on its products. The Company offers service contracts on its systems
directly and through its subsidiaries, distributors and representatives. The Company believes that maintaining a close
relationship with customers and providing them with ongoing engineering support improves customer satisfaction and
will provide the Company with a competitive advantage in selling its products to the Company’s customers.
BACKLOG
At May 31, 2023, the Company’s backlog was $24.5 million compared with $11.1 million at May 31, 2022. The
Company’s backlog consists of product orders for which confirmed purchase orders have been received and which are
scheduled for shipment within 12 months. Due to the possibility of customer changes in delivery schedules or
cancellations and potential delays in product shipments or development projects, the Company’s backlog as of a
particular date may not be indicative of net sales for any succeeding period.
RESEARCH AND PRODUCT DEVELOPMENT
The Company historically has devoted a significant portion of its financial resources to research and development
programs and expects to continue to allocate significant resources to these efforts. Certain research and development
expenditures related to non-recurring engineering milestones have been transferred to cost of goods sold, reducing
research and development expenses. The Company’s research and development expenses during fiscal 2023, 2022 and
2021 were $7.1 million, $5.8 million and $3.7 million, respectively.
8
The Company conducts ongoing research and development to design new products and to support and enhance
existing product lines. Building upon the expertise gained in the development of its existing products, the Company has
developed the FOX family of systems for performing test and burn-in of entire processed wafers, and burn-in of devices
in singulated die and module form, including the FOX-NP and FOX-CP systems released during fiscal 2019, and the
Automated WaferPak Aligner released during fiscal 2023. The Company is developing enhancements to our packaged
parts and wafer level burn-in products, intended to improve the capability and performance for testing and burn-in of
future generation devices and provide the flexibility in a wide variety of applications.
MANUFACTURING
The Company assembles its products from components and parts manufactured by others, including environmental
chambers, power supplies, metal fabrications, printed circuit assemblies, ICs, burn-in sockets, high-density interconnects,
wafer contactors and interconnect substrates. The Company’s strategy is to use in-house manufacturing only when
necessary to protect a proprietary process or when a significant improvement in quality, cost or lead time can be
achieved and relies on subcontractors to manufacture many of the components and subassemblies used in its products.
Final assembly and testing are performed at the Company’s principal manufacturing facility located in Fremont,
California.
COMPETITION
The semiconductor equipment industry is intensely competitive. Significant competitive factors in the
semiconductor equipment market include price, technical capabilities, quality, flexibility, automation, cost of ownership,
reliability, throughput, product availability and customer service. In each of the markets it serves, the Company faces
competition from established competitors and potential new entrants, many of which have greater financial, engineering,
manufacturing and marketing resources than the Company.
The Company expects its competitors to continue to improve the performance of their current products and to
introduce new products with improved price and performance characteristics. New product introductions by the
Company’s competitors or by new market entrants could cause a decline in sales or loss of market acceptance of the
Company’s products. The Company has observed price competition in the systems market, particularly with respect to
its less advanced products. Increased competitive pressure could also lead to intensified price-based competition,
resulting in lower prices which could adversely affect the Company’s operating margins and results. The Company
believes that to remain competitive it must invest significant financial resources in new product development and expand
its customer service and support worldwide. There can be no assurance that the Company will be able to compete
successfully in the future.
PROPRIETARY RIGHTS
The Company relies primarily on the technical and creative ability of its personnel, its proprietary software, and trade
secrets and copyright protection, rather than on patents, to maintain its competitive position. The Company’s
proprietary software is copyrighted and licensed to the Company’s customers. At May 31, 2023, the Company held 46
issued United States patents with expiration date ranges from 2023 to 2038 and had several additional United States
patent applications and foreign patent applications pending.
The Company’s ability to compete successfully is dependent in part upon its ability to protect its proprietary
technology and information. Although the Company attempts to protect its proprietary technology through patents,
copyrights, trade secrets and other measures, there can be no assurance that these measures will be adequate or that
competitors will not be able to develop similar technology independently. Further, there can be no assurance that claims
allowed on any patent issued to the Company will be sufficiently broad to protect the Company’s technology, that any
patent will be issued to the Company from any pending application or that foreign intellectual property laws will protect
the Company’s intellectual property. Litigation may be necessary to enforce or determine the validity and scope of the
Company’s proprietary rights, and there can be no assurance that the Company’s intellectual property rights, if
challenged, will be upheld as valid. Any such litigation could result in substantial costs and diversion of resources and
could have a material adverse effect on the Company’s business, financial condition and operating results, regardless of
the outcome of the litigation. In addition, there can be no assurance that any of the patents issued to the Company will
not be challenged, invalidated or circumvented or that the rights granted thereunder will provide competitive advantages
to the Company. Also, there can be no assurance that the Company will have the financial resources to defend its
patents from infringement or claims of invalidity.
There are currently no pending claims against the Company regarding infringement of any patents or other
intellectual property rights of others. However, the Company may, from time to time, receive communications from
third parties asserting intellectual property claims against the Company. Such claims could include assertions that the
Company’s products infringe, or may infringe, the proprietary rights of third parties, requests for indemnification against
9
such infringement or suggest the Company may be interested in acquiring a license from such third parties. There can
be no assurance that any such claim made in the future will not result in litigation, which could involve significant
expense to the Company, and, if the Company is required or deems it appropriate to obtain a license relating to one or
more products or technologies, there can be no assurance that the Company would be able to do so on commercially
reasonable terms, or at all.
ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG)
ENVIRONMENTAL
The Company focuses on clean technology such as the electrical vehicle (“EV”) and power semiconductor market.
EV and power semiconductor revenues accounted for 85%, 82%, and 23% of total revenues in fiscal 2023, 2022 and
2021, respectively. We engineer our products to be more energy efficient by using more efficient electrical designs and
thermally efficient cooling architectures using conductive heat transfer versus convection air cooled methods. Our
technology and architectural design allow our products to take up only 5% of the test floor space compared to
competitor’s products.
The Company improved our facility by replacing existing air conditioners and heat exchangers with higher efficiency
units that draw less power and produce less wasted energy. Our new headquarters facility upgrades include moving to
high efficiency lighting, modernizing our electrical power and cooling infrastructure, and adding Electric Vehicle
charging stations for employees, vendors, and customers.
SOCIAL
The Company reviews hiring and turnover quarterly and performs annual salary reviews, using independent third-
party data, to ensure competitive compensation practices. The Company performs annual employee surveys to evaluate
employee satisfaction. Glassdoor shows the Company at a 4.1 out of 5 rating as a great place to work.
The Company provides variable compensation on top of base salary for all employees including an employee profit
sharing plan. The Company also provides equity awards including stock options, restricted stock units (“RSUs”), and
participation in an employee stock purchase plan for regular full-time (“RFT”) employees located in the U.S. The
Company is restricted from issuing stock options or RSUs to non-U.S. employees in certain countries due to local
regulations. For those employees who are unable to participate in the Company’s equity incentive plan, the Company
maintains a stock appreciation bonus program to provide compensation linked to the Company’s stock price during a
predetermined period. The Company also provides a 401k plan, and a non-contributory Employee Stock Ownership
plan, for U.S. employees.
The Company provides recurring training in compliance with State of California regulations including sexual
harassment, prevention of violence in the workplace, and Diversity, Equity, and Inclusion (“DEI”) training. The
Company promotes employee engagement through corporate events or activities and maintains a “First Years” group to
encourage new hires to build comradery, and assist in recruiting efforts.
The Company provides health care coverage for all RFT employees, life insurance, continuing education assistance,
and reimbursement of employee health club membership. The Company ensures compliance with International
Organization for Standardization (“ISO”) certification and maintains safety training.
GOVERNANCE
The Company’s Board satisfies the diversity objectives of Nasdaq Rule 5605(f)(2) for Smaller Reporting Companies
with two directors who identify as female, representing 33% of the total six Board members. The Board members also
include individuals with Native American origin and multi-ethnicity. As the Company pursues future Board recruitment
efforts, the Nominating Committee will continue to seek candidates who can contribute to the diversity of views and
perspectives of the Board. This includes seeking out individuals of diverse ethnicities, a balance in terms of gender, and
individuals with diverse perspectives informed by other personal and professional experiences.
All employees and Board members sign a Code of Conduct and Ethics policy, and Insider Trading Policy upon hire.
All employees are provided with the employee handbook which addresses sexual harassment, confidentiality, and
Electronic Use Policy, among others. Each of Company’s directors and officers completes a Director and Officer
Questionnaire to identify conflicts of interest or areas of concern. The Company also maintains Audit, Compensation
and Nominating and Governance Committees to provide corporate oversight.
10
HUMAN CAPITAL RESOURCES
As of May 31, 2023, the Company, including its foreign subsidiaries and one branch office, employed 104 persons
collectively, on a regular full-time basis, of whom 23 were engaged in research, development and related engineering, 31
were engaged in manufacturing, 39 were engaged in marketing, sales and customer support and 11 were engaged in
general administration, finance and IT functions. In addition, the Company from time to time employs a number of
contractors, temporary, and part-time employees, particularly to perform customer support and manufacturing.
The Company’s employees are dispersed across principal offices in the United States, Germany, Taiwan, and
Philippines. In addition, our service and support organization has employees located worldwide, at or near customer
facilities, to provide timely customer response. As of May 31, 2023 regular full-time employees were located in the
following geographic areas: 80 United States, 1 Germany, 5 Taiwan, and 18 in the Philippines.
The Company’s success is in part dependent on its ability to attract and retain highly skilled workers, who are in high
demand. None of the Company’s employees are represented by a union and the Company has never experienced a
work stoppage. The Company’s management considers its relations with its employees to be good. The Company
regularly evaluates its ability to attract and retain its employees. The Company has had relatively low turnover rates
within its workforce, with 58% of its regular full-time workforce being with the Company for 5 years or more.
The Company believes that the investments we make in driving a strong, values-based culture and supporting its
employees through programs, development, and competitive pay enhances its organizational capability. Company
management quarterly reviews retention and turnover, employee communications, performance review status, and
compensation and benefits to identify potential issues or opportunities. The Company periodically performs employee
surveys to monitor employee satisfaction and the Company follows-up with an action planning process to actively
respond to employee feedback.
BUSINESS SEGMENT DATA AND GEOGRAPHIC AREAS
The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced
test and burn-in products to the semiconductor manufacturing industry in several geographic areas. Selected financial
information, including net sales and property and equipment, net for each of the last three fiscal years, by geographic
area is included in Part II, Item 8, Note 2, “Revenue” and Note 17, “Segment Information” and certain risks related to
such operations are discussed in Part I, Item 1A, Risk Factors, under the heading “We sell our products and services
worldwide, and our business is subject to risks inherent in conducting business activities in geographic regions outside of
the United States.”
AVAILABLE INFORMATION
The Company’s common stock trades on the NASDAQ Capital Market under the symbol “AEHR.” The
Company’s annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and
amendments to these reports that are filed with the United States Securities and Exchange Commission, or SEC,
pursuant to Section 13(a) or 15(d) of the Exchange Act, are available free of charge through the Company’s website at
www.aehr.com as soon as reasonably practicable after we electronically file them with, or furnish them to the SEC.
The public may read and copy any materials filed by the Company with the SEC at the SEC’s Public Reference Room
at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operations of the Public
Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site, www.sec.gov, that
contains reports, proxy and information statements and other information regarding issuers that file electronically with
the SEC.
In addition, information regarding the Company’s code of conduct and ethics and the charters of its Audit,
Compensation and Nominating and Governance Committees, are available free of charge on the Company’s website
listed above.
Item 1A.
Risk Factors
You should carefully consider the risks described below. These risks are not the only risks that we may face.
Additional risks and uncertainties that we are unaware of, or that we currently deem immaterial, also may become
important factors that affect us. If any of the following risks occur, our business, financial condition or results of
operations could be materially and adversely affected which could cause our actual operating results to differ materially
from those indicated or suggested by forward-looking statements made in this Annual Report on Form 10-K or
presented elsewhere by management from time to time.
11
Risks Related to our Business and Industry
We generate a large portion of our sales from a small number of customers. If we were to lose one or more of
our large customers, operating results could suffer dramatically.
The semiconductor manufacturing industry is highly concentrated, with a relatively small number of large
semiconductor manufacturers and contract assemblers accounting for a substantial portion of the purchases of
semiconductor equipment. Sales to our five largest customers accounted for approximately 97%, 98%, and 84% of our
net sales in fiscal 2023, 2022 and 2021, respectively. During fiscal 2023, two customers accounted for approximately
79% and 10% of our net sales. During fiscal 2022, one customer accounted for approximately 82% of our net sales.
During fiscal 2021, four customers accounted for approximately 24%, 23%, 20% and 10%, respectively, of our net sales.
No other customers accounted for more than 10% of our net sales for any of these periods.
We expect that sales of our products to a limited number of customers will continue to account for a high percentage
of our net sales for the foreseeable future. In addition, sales to particular customers may fluctuate significantly from
quarter to quarter. The loss of, or reduction or delay of, an order or orders from a significant customer or customers, or
a delay in collecting or failure to collect accounts receivable from a significant customer or customers, could adversely
affect our business, financial condition and operating results.
The semiconductor equipment industry is intensely competitive. In each of the markets we serve, we face
competition from established competitors and potential new entrants, many of which have greater financial,
engineering, manufacturing and marketing resources than us.
Our FOX wafer-level and singulated die/module test and burn in systems face competition from larger systems
manufacturers that have significant technological know-how and manufacturing capability. Some users of our systems,
such as independent test labs, build their own burn-in systems, while others, particularly large IC manufacturers in Asia,
acquire burn-in systems from captive or affiliated suppliers. Our WaferPak products are facing and are expected to face
increasing competition. Several companies have developed or are developing full-wafer and single-touchdown probe
cards. The Company expects that its DiePak products for burning-in and testing multiple singulated die and small
modules face significant competition. The Company believes that several companies have developed or are developing
products which are intended to enable test and burn-in of multiple bare die, and small modules.
We expect our competitors to continue to improve the performance of their current products and to introduce new
products with improved price and performance characteristics. New product introductions by our competitors or by
new market entrants could cause a decline in sales or loss of market acceptance of our products. We have observed
price competition in the systems market, particularly with respect to its less advanced products. Increased competitive
pressure could also lead to intensified price-based competition, resulting in lower prices which could adversely affect our
operating margins and results. We believe that to remain competitive we must invest significant financial resources in
new product development and expand our customer service and support worldwide. There can be no assurance that we
will be able to compete successfully in the future.
We rely on increasing market acceptance for our FOX system, and we may not be successful in attracting new
customers or maintaining our existing customers.
A principal element of our business strategy is to increase our presence in the test equipment market through system
sales in our FOX wafer-level and singulated die/module test and burn-in product family. Market acceptance of the
FOX system is subject to a number of risks. Before a customer will incorporate the FOX system into a production line,
lengthy qualification and correlation tests must be performed. We anticipate that potential customers may be reluctant
to change their procedures in order to transfer burn-in and test functions to the FOX system. Initial purchases are
expected to be limited to systems used for these qualifications and for engineering studies. Market acceptance of the
FOX system also may be affected by a reluctance of IC manufacturers to rely on relatively small suppliers such as us. As
is common with new complex products incorporating leading-edge technologies, we may encounter reliability, design
and manufacturing issues as we begin volume production and initial installations of FOX systems at customer sites. The
failure of the FOX system to achieve increased market acceptance would have a material adverse effect on our future
operating results, long-term prospects and our stock price.
A substantial portion of our net sales is generated by relatively small volume, high value transactions.
We derive a substantial portion of our net sales from the sale of a relatively small number of systems with high dollar
value. As a result, the loss or deferral of a limited number of system sales could have a material adverse effect on our net
sales and operating results in a particular period. Most customer purchase orders are subject to cancellation or
rescheduling by the customer with limited penalties, and, therefore, backlog at any particular date is not necessarily
indicative of actual sales for any succeeding period. From time to time, cancellations and rescheduling of customer
12
orders have occurred, and delays by our suppliers in providing components or subassemblies to us have caused delays in
our shipments of our own products. There can be no assurance that we will not be materially adversely affected by
future cancellations or rescheduling by our customers or other delays in our shipments. For non-standard products
where we have not effectively demonstrated the ability to meet specifications in the customer environment, we defer
revenue until we have met such customer specifications. Any delay in meeting customer specifications could have a
material adverse effect on our operating results. A substantial portion of net sales typically are realized near the end of
each quarter. A delay or reduction in shipments near the end of a particular quarter, due, for example, to unanticipated
shipment rescheduling, cancellations or deferrals by customers, customer credit issues, unexpected manufacturing
difficulties experienced by us or delays in deliveries by suppliers, could cause net sales in a particular quarter to fall
significantly.
We may experience increased costs associated with new product introductions.
As is common with new complex products incorporating leading-edge technologies, we have encountered reliability,
design and manufacturing issues as we begin volume production and initial installations of certain products at customer
sites. Some of these issues in the past have been related to components and subsystems supplied to us by third parties
who have in some cases limited the ability of us to address such issues promptly. This process in the past required and
in the future is likely to require us to incur un-reimbursed engineering expenses and to experience larger than anticipated
warranty claims which could result in product returns. In the early stages of product development there can be no
assurance that we will discover any reliability, design and manufacturing issues or, that if such issues arise, that they can
be resolved to the customers’ satisfaction or that the resolution of such problems will not cause us to incur significant
development costs or warranty expenses or to lose significant sales opportunities.
The Company is exposed to cybersecurity threats or incidents.
We collect, maintain, and transmit data on information systems. These systems include those owned and maintained
by the Company or by third parties. In addition, we use cloud-based enterprise resource planning, ERP, software to
manage the business integrating all facets of operations, including manufacturing, finance, and sales and marketing. The
data maintained on these systems includes confidential and proprietary information belonging to us, our customers,
suppliers, and others. While the Company devotes significant resources to protect its systems and data from
unauthorized access or misuse, we are exposed to cybersecurity risks. Our systems are subject to computer viruses, data
breach, phishing schemes, and other malicious software programs or attacks. We have experienced cyber threats and
incidents in the past. Although past threats and incidents have not resulted in a material adverse effect, cybersecurity
incidents may result in business disruption, loss of data, or unauthorized access to intellectual property which could
adversely affect our business.
Our industry is subject to rapid technological change and our ability to remain competitive depends on our
ability to introduce new products in a timely manner.
The semiconductor equipment industry is subject to rapid technological change and new product introductions and
enhancements. Our ability to remain competitive depends in part upon our ability to develop new products and to
introduce them at competitive prices and on a timely and cost-effective basis. Our success in developing new and
enhanced products depends upon a variety of factors, including product selection, timely and efficient completion of
product design, timely and efficient implementation of manufacturing and assembly processes, product performance in
the field and effective sales and marketing. Because new product development commitments must be made well in
advance of sales, new product decisions must anticipate both future demand and the technology that will be available to
supply that demand. Furthermore, introductions of new and complex products typically involve a period in which
design, engineering and reliability issues are identified and addressed by our suppliers and by us. There can be no
assurance that we will be successful in selecting, developing, manufacturing and marketing new products that satisfy
market demand. Any such failure would materially and adversely affect our business, financial condition and results of
operations.
Because of the complexity of our products, significant delays can occur between a product’s introduction and the
commencement of the volume production of such product. We have experienced, from time to time, significant delays
in the introduction of, and technical and manufacturing difficulties with, certain of our products and may experience
delays and technical and manufacturing difficulties in future introductions or volume production of our new products.
Our inability to complete new product development, or to manufacture and ship products in time to meet customer
requirements would materially adversely affect our business, financial condition and results of operations.
A decrease in customer device failure rates may result in a decrease in demand for our products.
Customer tool utilization is driven by many factors including failure rates of customer devices. Improvements in
yield may result in customers decreasing test and burn-in times, or electing to perform sampling rather than 100% burn-
13
in of their devices. Based upon data obtained from our systems customers may revise internal manufacturing processes
to decrease failure rates. A decrease in customer tool utilization may result in a decrease in demand for our products
impacting our business and results of operations.
Future changes in semiconductor technologies may make our products obsolete.
Future improvements in semiconductor design and manufacturing technology may reduce or eliminate the need for
our products. For example, improvements in semiconductor process technology and improvements in conventional test
systems, such as reduced cost or increased throughput, may significantly reduce or eliminate the market for one or more
of our products. If we are not able to improve our products or develop new products or technologies quickly enough to
maintain a competitive position in our markets, our business may decline.
Operational and Other Risks
Supply chain issues, including a shortage of critical components or contract manufacturing capacity, could
result in a delay in fulfillment of customer orders, or an increase in costs, resulting in an adverse impact on our
business and operating results.
Our sales growth depends on our ability to obtain timely deliveries of parts from our suppliers and contract
manufacturers. There is currently a market shortage of semiconductor and other component supply which has affected,
and could further affect, lead times, the cost of supply, and our ability to meet customer demand for our products. While
we have taken steps to obtain an assurance of supply from our key suppliers, the market shortage of semiconductor
supply may impact our ability to meet customer order fulfillments, or result in a significant increase in costs of our
inventories. Manufacturing issues or capacity problems experienced by our suppliers or contract manufacturers could
impact our ability to secure sufficient supply of critical components. Due to the market shortage of semiconductor
supply, suppliers and contract manufacturers may commit their capacity to others, limiting our supplies or increasing
costs. The failure to obtain timely delivery of supplies, or a significant increase in costs, could result in a material impact
in our business and results from operations.
We sell our products and services worldwide, and our business is subject to risks inherent in conducting
business activities in geographic regions outside of the United States.
Approximately 86%, 90%, and 68% of our net sales in fiscal 2023, 2022 and 2021, respectively, were attributable to
sales to customers for delivery outside of the United States. We provide sales and service in North America and Taiwan,
operate a sales organization in Germany and a service organization in the Philippines, as well as direct support through
third party agreements in China and South Korea. We expect that sales of products for delivery outside of the United
States will continue to represent a substantial portion of our future sales. Our future performance will depend, in
significant part, upon our ability to continue to compete in foreign markets which in turn will depend, in part, upon a
continuation of current trade relations between the United States and foreign countries in which semiconductor
manufacturers or assemblers have operations. A change toward more protectionist trade legislation in either the United
States or such foreign countries, such as a change in the current tariff structures, export compliance or other trade
policies, could adversely affect our ability to sell our products in foreign markets. In addition, we are subject to other
risks associated with doing business internationally, including longer receivable collection periods and greater difficulty in
accounts receivable collection, the burden of complying with a variety of foreign laws, difficulty in staffing and managing
global operations, risks of civil disturbance or other events which may limit or disrupt markets, international exchange
restrictions, changing political conditions and monetary policies of foreign governments.
Our net sales for fiscal 2023 were primarily denominated in U.S. Dollars. However, because a substantial portion of
our net sales is from sales of products for delivery outside the United States, an increase in the value of the U.S. Dollar
relative to foreign currencies would increase the cost of our products compared to products sold by local companies in
such markets. In addition, since the price is determined at the time a purchase order is accepted, we are exposed to the
risks of fluctuations in the U.S. Dollar exchange rate during the lengthy period from the date a purchase order is received
until payment is made. This exchange rate risk is partially offset to the extent our foreign operations incur expenses in
the local currency. To date, we have not invested in any instruments designed to hedge currency risks. Our operating
results could be adversely affected by fluctuations in the value of the U.S. Dollar relative to other currencies.
We purchase materials from suppliers worldwide, which subjects the Company to increased risk.
We purchase components, sub-assemblies, and chambers from suppliers outside the United States. Increases in
tariffs, additional taxes, or trade barriers may result in an increase in our manufacturing costs. A decrease in the value of
the U.S. Dollar relative to foreign currencies would increase the cost of our materials. Should the Company increase its
sales prices to recover the increase in costs, this could result in a decrease in the competitiveness of our products. In
addition, we are subject to other risks associated with purchasing materials from suppliers worldwide. Government
14
authorities may also implement protectionist policies or impose limitations on the transfer of intellectual property. This
may limit our ability to obtain products from certain geographic regions and require us to identify and qualify new
suppliers. The process of qualifying suppliers could be lengthy, and no assurance can be given that any additional
sources would be available to us on a timely basis. Changes in trade relations, currency fluctuations, or protectionist
policies could have a material adverse effect on our business, financial condition or results of operations.
Global unrest may impact our ability to sell our products or obtain critical materials.
Global economic uncertainty and financial market volatility caused by political instability, changes in international
trade relationships and conflicts, such as the conflict between Russia and Ukraine and the political climate in China and
Taiwan may result in limited access to these markets for sales and material purchases. Periods of macroeconomic
weakness or recession and heightened market volatility caused by adverse geopolitical developments could increase these
risks, potentially resulting in adverse impacts on our business operations. Increased energy costs in Europe, resulting
from Russia’s limiting energy supplies in the region, may result in an economic downturn or an increase in the cost of
materials. The recent decline in relations between the United States and China, and relations between China and
Taiwan, may result in the imposition of trade restrictions with China or Taiwan. While we have limited sales in Europe
and Taiwan, and procurement from these regions, unrest in these areas may result in a decrease in sales of our products,
or an increase in costs of materials and services.
Our dependence on subcontractors and sole source suppliers may prevent us from delivering our products on
a timely basis and expose us to intellectual property infringement.
We rely on subcontractors to manufacture many of the components or subassemblies used in our products. Our
FOX systems, WaferPak contactors, DiePak carriers, WaferPak Aligners, and DiePak Loaders contain several
components, including environmental chambers, power supplies, high-density interconnects, wafer contactors, module
contactors, signal distribution substrates, and certain ICs that are currently supplied by only one or a limited number of
suppliers. Our reliance on subcontractors and single source suppliers involves a number of significant risks, including
the loss of control over the manufacturing process, the potential absence of adequate capacity and reduced control over
delivery schedules, manufacturing yields, quality and costs. In the event that any significant subcontractor or single
source supplier is unable or unwilling to continue to manufacture subassemblies, components or parts in required
volumes, we would have to identify and qualify acceptable replacements. The process of qualifying subcontractors and
suppliers could be lengthy, and no assurance can be given that any additional sources would be available to us on a
timely basis. Any delay, interruption or termination of a supplier relationship could adversely affect our ability to deliver
products, which would harm our operating results.
Our suppliers manufacture components, tooling, and provide engineering services. During this process, our
suppliers are allowed access to our intellectual property. While we maintain patents to protect from intellectual property
infringement, there can be no assurance that technological information gained in the manufacture of our products will
not be used to develop a new product, improve processes or techniques which compete against our products. Litigation
may be necessary to enforce or determine the validity and scope of our proprietary rights, and there can be no assurance
that our intellectual property rights, if challenged, will be upheld as valid.
Tightening of fiscal monetary policy, and periodic economic and semiconductor industry downturns could
negatively affect our business, results of operations and financial condition.
Inflation reached a 40-year high during 2022, and market rates of interest have risen after a prolonged period at
historical lows. The increase in inflation has resulted in a tightening of world-wide monetary policy, which in turn has
resulted in an increase in the cost of credit. Financial turmoil in the banking system and financial markets has resulted,
and may result in the future, in a tightening of the credit markets, disruption in the financial markets and global economy
downturn. Periodic global economic and semiconductor industry downturns have negatively affected and could
continue to negatively affect our business, results of operations, and financial condition. These events may contribute to
significant slowdowns in the industry in which we operate. Difficulties in obtaining capital and deteriorating market
conditions can pose the risk that some of our customers may not be able to obtain necessary financing on reasonable
terms, which could result in lower sales. Customers with liquidity issues may lead to additional bad debt expense.
Turmoil in the international financial markets has resulted, and may result in the future, in dramatic currency
devaluations, stock market declines, restriction of available credit and general financial weakness. In addition, flash
memory and other similar device prices have historically declined and will likely do so again in the future. These
developments may affect us in several ways. The market for semiconductors and semiconductor capital equipment has
historically been cyclical, and we expect this to continue in the future. The uncertainty of the semiconductor market may
cause some manufacturers in the future to further delay capital spending plans. Economic conditions may also affect the
ability of our customers to meet their payment obligations, resulting in cancellations or deferrals of existing orders and
limiting additional orders. In addition, some governments have subsidized portions of fabrication facility construction,
15
and financial turmoil may reduce these governments’ willingness to continue such subsidies. Such developments could
have a material adverse effect on our business, financial condition and results of operations.
The current economic conditions and uncertainty about future economic conditions make it challenging for us to
forecast our operating results, make business decisions, and identify the risks that may affect our business, financial
condition and results of operations. If such conditions recur, and we are not able to timely and appropriately adapt to
changes resulting from the difficult macroeconomic environment, our business, financial condition or results of
operations may be materially and adversely affected.
If we are not able to reduce our operating expenses sufficiently during periods of weak revenue, or if we utilize
significant amounts of cash to support operating losses, we may erode our cash resources and may not have
sufficient cash to operate our business.
We have in the past, in the face of a downturn in our business and a decline in our net sales, implemented a variety of
cost controls and restructured our operations with the goal of reducing our operating costs to position ourselves to more
effectively meet the needs of the then weak market for test and burn-in equipment. While we took significant steps to
minimize our expense levels and to increase the likelihood that we would have sufficient cash to support operations
during the downturn, we have experienced historical operating losses. We anticipate that our existing cash balance
together with income from operations, collections of existing accounts receivable, revenue from our existing backlog of
products, the sale of inventory on hand, and deposits and down payments against significant orders, and available
balance under our ATM offering, will be adequate to meet our working capital and capital equipment requirements.
Depending on our rate of growth and profitability, and our ability to obtain significant orders with down payments, we
may require additional equity or debt financing to meet our working capital requirements or capital equipment needs.
There can be no assurance that additional financing will be available when required, or if available, that such financing
can be obtained on terms satisfactory to us.
We may be subject to litigation relating to intellectual property infringement which would be time-consuming,
expensive and a distraction from our business.
If we do not adequately protect our intellectual property, competitors may be able to use our proprietary information
to erode our competitive advantage, which could harm our business and operating results. Litigation may be necessary
to enforce or determine the validity and scope of our proprietary rights, and there can be no assurance that our
intellectual property rights, if challenged, will be upheld as valid. Such litigation could result in substantial costs and
diversion of resources and could have a material adverse effect on our operating results, regardless of the outcome of the
litigation. In addition, there can be no assurance that any of the patents issued to us will not be challenged, invalidated
or circumvented or that the rights granted thereunder will provide competitive advantages to us.
There are no pending claims against us regarding infringement of any patents or other intellectual property rights of
others. However, in the future we may receive communications from third parties asserting intellectual property claims
against us. Such claims could include assertions that our products infringe, or may infringe, the proprietary rights of
third parties, requests for indemnification against such infringement or suggestions that we may be interested in
acquiring a license from such third parties. There can be no assurance that any such claim will not result in litigation,
which could involve significant expense to us, and, if we are required or deem it appropriate to obtain a license relating
to one or more products or technologies, there can be no assurance that we would be able to do so on commercially
reasonable terms, or at all.
While we believe we have complied with all applicable environmental laws, our failure to do so could adversely
affect our business as a result of having to pay substantial amounts in damages or fees.
Federal, state and local regulations impose various controls on the use, storage, discharge, handling, emission,
generation, manufacture and disposal of toxic and other hazardous substances used in our operations. We believe that
our activities conform in all material respects to current environmental and land use regulations applicable to our
operations and our current facilities, and that we have obtained environmental permits necessary to conduct our
business. Nevertheless, failure to comply with current or future regulations could result in substantial fines, suspension
of production, alteration of our manufacturing processes or cessation of operations. Such regulations could require us
to acquire expensive remediation equipment or to incur substantial expenses to comply with environmental regulations.
Any failure to control the use, disposal or storage of or adequately restrict the discharge of, hazardous or toxic
substances could subject us to significant liabilities.
16
Risks Related to Ownership of our Common Stock
Our stock price may fluctuate.
The price of our common stock has fluctuated in the past and may fluctuate significantly in the future. We believe
that factors such as announcements of developments related to our business, fluctuations in our operating results,
general conditions in the semiconductor and semiconductor equipment industries as well as the worldwide economy,
announcement of technological innovations, new systems or product enhancements by us or our competitors,
fluctuations in the level of cooperative development funding, acquisitions, changes in governmental regulations,
developments in patents or other intellectual property rights and changes in our relationships with customers and
suppliers could cause the price of our common stock to fluctuate substantially. In addition, in recent years the stock
market in general, and the market for small capitalization and high technology stocks in particular, have experienced
extreme price fluctuations which have often been unrelated to the operating performance of the affected companies.
Such fluctuations could adversely affect the market price of our common stock.
Increased scrutiny and changing expectations from stakeholders with respect to the Company’s ESG practices
may result in additional costs or risks.
Companies across many industries are facing increasing scrutiny related to their ESG practices. Investor advocacy
groups, certain institutional investors, investment funds and other influential investors are also increasingly focused on
ESG practices and in recent years have placed increasing importance on the non-financial impacts of their investments.
If our ESG practices do not meet investor or other industry stakeholder expectations, which continue to evolve, we may
incur additional costs and our brand, ability to attract and retain qualified employees and business may be harmed.
Risks Related to our Legal/Organizational Structure
We depend on our key personnel and our success depends on our ability to attract and retain talented
employees.
Our success depends to a significant extent upon the continued service of Gayn Erickson, our President and Chief
Executive Officer, as well as other executive officers and key employees. We do not maintain key person life insurance
for our benefit on any of our personnel, and none of our employees are subject to a non-competition agreement with us.
The loss of the services of any of our executive officers or a group of key employees could have a material adverse effect
on our business, financial condition and operating results. Our future success will depend in significant part upon our
ability to attract and retain highly skilled technical, management, sales and marketing personnel. There are a limited
number of personnel with the requisite skills to serve in these positions, and it has become increasingly difficult for us to
hire such personnel. Competition for such personnel in the semiconductor equipment industry is intense, and there can
be no assurance that we will be successful in attracting or retaining such personnel. Changes in management could
disrupt our operations and adversely affect our operating results.
If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of
our financial reporting may be adversely affected.
We are required to comply with Section 404 of the Sarbanes-Oxley Act of 2002. The provisions of the act require,
among other things, that we maintain effective internal control over financial reporting and disclosure controls and
procedures. Preparing our financial statements involves a number of complex processes, many of which are done
manually and are dependent upon individual data input or review. These processes include, but are not limited to,
calculating revenue, deferred revenue and inventory costs. While we continue to automate our processes and enhance
our review and put in place controls to reduce the likelihood for errors, we expect that for the foreseeable future, many
of our processes will remain manually intensive and thus subject to human error.
The collapse of certain U.S. banks and potentially other financial institutions may have adverse impacts on our
business.
On March 10, 2023, Silicon Valley Bank (“SVB”) was shut down, followed on March 11, 2023 by Signature Bank and
the Federal Deposit Insurance Corporation was appointed as receiver for those banks. Since that time, there have been
reports of instability at other U.S. banks. The Company’s cash and investment balances held at banks and brokerage
firms may at time exceed federally insured levels. On March 15, 2023, the Company filed a Current Report on Form 8-
K with the SEC, disclosing its exposure to SVB and stating that the Company did not expect a significant impact on its
operations.
17
Item 1B.
Unresolved Staff Comments
None.
Item 2.
Properties
The Company’s principal administrative and production facilities are located in Fremont, California, in a 51,289
square foot building. The Company’s lease was renewed in December 2022 and expires in September 2030. The
Company leases a 492 square foot sales and support office in Utting, Germany. The lease, which began February 1,
1992 and expires on January 31, 2025, contains an automatic twelve months renewal, at rates to be determined, if no
notice is given prior to six months from expiration. On November 18, 2020, the Company established a wholly owned
subsidiary, Aehr Test Systems Philippines Inc., which has been in full operation since March 2021. The Company leases
a facility in Philippines located in a 2,713 square foot building in Clark Freeport Zone, Pampanga. The lease, which
began January 1, 2021 and expires on December 31, 2025, contains an option to renew for another three years at rates
stipulated in the contract, notice for renewal is given six months from expiration. The Company periodically evaluates
its global operations and facilities to bring its capacity in line with demand and to provide cost efficient services for its
customers. In prior years, through this process, the Company has moved from certain facilities that exceeded the
capacity required to satisfy its needs. The Company believes that its existing facilities in Fremont, California are
adequate to meet its current and reasonably foreseeable requirements. The Company regularly evaluates its expected
future facilities requirements and believes that alternate facilities would be available if needed.
Item 3.
Legal Proceedings
None.
Item 4.
Mine Safety Disclosures
Not Applicable
PART II
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Equity Securities
The Company’s common stock is publicly traded on the NASDAQ Capital Market under the symbol “AEHR”. The
following table sets forth, for the periods indicated, the high and low sale prices for the common stock on such market.
These quotations represent prices between dealers and do not include retail markups, markdowns or commissions and
may not necessarily represent actual transactions.
Fiscal 2023:
First quarter ended August 31, 2022 ..........................................................................................
Second quarter ended November 30, 2022 ...............................................................................
Third quarter ended February 28, 2023 ..........................................................................................
Fourth quarter ended May 31, 2023 ...........................................................................................
Fiscal 2022:
First quarter ended August 31, 2021 ..........................................................................................
Second quarter ended November 30, 2021 ...............................................................................
Third quarter ended February 28, 2022 ..........................................................................................
Fourth quarter ended May 31, 2022 ...........................................................................................
High
Low
$19.43
27.00
37.57
40.69
$8.60
27.09
24.70
13.94
$6.71
13.00
17.05
23.11
$2.25
6.83
10.20
6.86
At August 3, 2023, the Company had 86 holders of record of its common stock. A substantially greater number of
holders of the Company’s common stock are “street name” or beneficial holders whose shares are held by banks,
brokers and other financial institutions.
The Company has not paid cash dividends on its common stock or other securities. The Company currently
anticipates that it will retain its future earnings, if any, for use in the expansion and operation of its business and does
not anticipate paying any cash dividends on its common stock in the foreseeable future.
The Company did not repurchase any of its common stock during the fiscal year ended May 31, 2023.
18
Item 6. [Reserved]
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of the financial condition and results of operations should be read in
conjunction with our “Selected Consolidated Financial Data” and our consolidated financial statements and related
notes included elsewhere in this Annual Report on Form 10-K.
OVERVIEW
Aehr Test Systems (“Aehr Test”, “Aehr” or “We”) is a leading provider of test solutions for testing, burning-in, and
stabilizing semiconductor devices in wafer level, singulated die, and package part form, and has installed thousands of
systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple
applications, including electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, data
and telecommunications infrastructure, and solid-state memory and storage, are driving additional test requirements,
incremental capacity needs, and new opportunities for Aehr Test products and solutions.
We have developed and introduced several innovative products including the FOX-P family of test and burn-in
systems and FOX WaferPak Aligner, FOX WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader. The
FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test,
burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power
semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory
semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The
FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest
addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full wafer contactor capable of
testing wafers up to 300mm that enables Integrated Circuit manufacturers to perform test, burn-in, and stabilization of
full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated
bare die and modules up to 1,024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine
DiePaks at a time.
Our net sales consist primarily of sales of FOX-P systems, WaferPak Aligners and DiePak Loaders, WaferPak
contactors, DiePak carriers, test fixtures, upgrades and spare parts, service contracts revenues, and non-recurring
engineering charges. Our selling arrangements may include contractual customer acceptance provisions, which are
mostly deemed perfunctory or inconsequential, and installation of the product occurs after shipment, transfer of title and
risk of loss.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our discussion and analysis of our financial condition and results of operations are based upon our consolidated
financial statements, which have been prepared in accordance with accounting principles generally accepted in the
United States of America. The preparation of these consolidated financial statements requires us to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to customer
programs and incentives, product returns, bad debts, inventories, investments, income taxes, financing operations,
warranty obligations, and long-term service contracts, among others. Our estimates are derived from historical
experience and on various other assumptions that are believed to be reasonable under the circumstances. Those results
form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different assumptions or conditions.
We believe the following critical accounting policies affect our more significant judgments and estimates used in the
preparation of our consolidated financial statements.
REVENUE RECOGNITION
The Company recognizes revenue when promised goods or services are transferred to customers in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by
following a five-step process: (1) identify the contract with a customer, (2) identify the performance obligations in the
contract, (3) determine the transaction price, (4) allocate the transaction price, and (5) recognize revenue when or as the
Company satisfies a performance obligation, as further described below.
Performance obligations include sales of systems, contactors, spare parts, and services, as well as installation and
training services included in customer contracts.
19
A contract’s transaction price is allocated to each distinct performance obligation. In determining the transaction
price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to
which the Company expects to be entitled. The Company generally does not grant return privileges, except for defective
products during the warranty period.
For contracts that contain multiple performance obligations, the Company allocates the transaction price to the
performance obligations on a relative standalone selling price basis. Standalone selling prices are based on multiple
factors including, but not limited to, historical discounting trends for products and services and pricing practices in
different geographies.
Revenue for systems and spares are recognized at a point in time, which is generally upon shipment or delivery.
Revenue from services is recognized over time as services are completed or ratably over the contractual period of
generally one year or less.
The Company has elected the practical expedient to not assess whether a contract has a significant financing
component as the Company’s standard payment terms are less than one year.
We sell our products primarily through a direct sales force. In certain international markets, we sell our products
through independent distributors.
Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to
provide additional services.
ALLOWANCE FOR DOUBTFUL ACCOUNTS
We maintain an allowance for doubtful accounts to reserve for potentially uncollectible trade receivables. We also
review our trade receivables by aging category to identify specific customers with known disputes or collection issues.
We exercise judgment when determining the adequacy of these reserves as we evaluate historical bad debt trends, general
economic conditions in the United States and internationally and changes in customer financial conditions.
Uncollectible receivables are recorded as bad debt expense when all efforts to collect have been exhausted and
recoveries are recognized when they are received.
WARRANTY OBLIGATIONS
We provide and record the estimated cost of product warranties at the time revenues are recognized on products
shipped. While we engage in extensive product quality programs and processes, including actively monitoring and
evaluating the quality of our component suppliers, our warranty obligation is affected by product failure rates, material
usage and service delivery costs incurred in correcting a product failure. Our estimate of warranty reserve is based on
management’s assessment of future warranty obligations and on historical warranty obligations. Should actual product
failure rates, material usage or service delivery costs differ from our estimates, revisions to the estimated warranty liability
would be required.
INVENTORY OBSOLESCENCE
In each of the last three fiscal years, we wrote down our inventory for estimated obsolescence or unmarketable
inventory by an amount equal to the difference between the cost of inventory and the net realizable value based upon
assumptions about future demand and market conditions, see Note 7, “Balance Sheet Detail.” If future market
conditions are less favorable than those projected by management, additional inventory write-downs may be required.
INCOME TAXES
Income taxes are accounted for under the asset-and-liability method as required by the Financial Accounting
Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“ASC 740”).
Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the
financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and
tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on
deferred tax assets and liabilities of a change in tax rates is recognized in income in the period corresponding to the
enactment date. Under ASC 740, a valuation allowance is required when it is more likely than not all or some portion of
the deferred tax assets will not be realized through generating sufficient future taxable income.
20
As of May 31, 2023 the Company maintained a full valuation allowance against its deferred tax assets. We will
continue to assess whether sufficient future taxable income will be generated to permit the use of deferred tax assets, and
will reverse all or a portion of the allowance when there is sufficient evidence to support the reversal. Based upon our
prior two fiscal years of profitability, the outlook for the next fiscal year, and absent any additional objective negative
evidence, the Company anticipates adjusting the current valuation allowance position in fiscal 2024.
FASB ASC Subtopic 740-10, Accounting for Uncertainty of Income Taxes, (“ASC 740-10”) defines the criterion an
individual tax position must meet for any part of the benefit of the tax position to be recognized in financial statements
prepared in conformity with GAAP. The Company may recognize the tax benefit from an uncertain tax position only if
it is more likely than not such tax position will be sustained on examination by the taxing authorities, based solely on the
technical merits of the respective tax position. The tax benefits recognized in the financial statements from such a tax
position should be measured based on the largest benefit having a greater than 50% likelihood of being realized upon
ultimate settlement with the tax authority. In accordance with the disclosure requirements of ASC 740-10, the
Company’s policy on income statement classification of interest and penalties related to income tax obligations is to
include such items as part of income taxes.
STOCK-BASED COMPENSATION EXPENSE
Stock-based compensation expense consists of expenses for stock options, restricted stock units, or RSUs, and
employee stock purchase plan, or ESPP, purchase rights. Stock-based compensation cost for stock options and ESPP
purchase rights is measured at each grant date, based on the fair value of the award using the Black-Scholes option
valuation model, and is recognized as expense over the employee’s requisite service period. This model was developed
for use in estimating the value of publicly traded options that have no vesting restrictions and are fully transferable. Our
employee stock options have characteristics significantly different from those of publicly traded options. For RSUs,
stock-based compensation expense is based on the fair value of our common stock at the grant date, and is recognized
as expense over the employee’s requisite service period. All of our stock-based compensation is accounted for as an
equity instrument.
The fair value of each option grant and the right to purchase shares under our ESPP are estimated on the date of
grant using the Black-Scholes option valuation model with assumptions concerning expected term, stock price volatility,
expected dividend yield, risk-free interest rate and the expected life of the award. See Note 13 to our consolidated
financial statements for detailed information relating to stock-based compensation and the stock option plan and the
ESPP.
RESULTS OF OPERATIONS
The following table sets forth statements of operations data as a percentage of net sales for the periods indicated.
Net sales
Cost of sales
Gross profit
Operating expenses:
Selling, general and administrative
Research and development
2023
Year Ended May 31,
2022
2021
100.0%
49.6
50.4
100.0%
53.4
46.6
100.0%
63.7
36.3
18.8
11.0
19.8
11.5
39.5
22.0
Total operating expenses
29.8
31.3
61.5
Income (loss) from operations
20.6
15.3
(25.2)
Interest income (expense), net
Net gain from dissolution of Aehr Test Systems Japan
Gain from forgiveness of PPP loan
Other (expense) income, net
1.9
--
--
--
0.1
--
3.3
0.1
(0.3)
13.2
--
(1.0)
Income (loss) before income tax (expense) benefit
22.5
18.8
(13.3)
Income tax (expense) benefit
Net income (loss)
(0.1)
(0.2)
1.1
22.4%
18.6%
(12.2)%
21
FISCAL YEAR ENDED MAY 31, 2023 COMPARED TO FISCAL YEAR ENDED MAY 31, 2022
NET SALES. Net sales increased to $65.0 million for the fiscal year ended May 31, 2023 from $50.8 million for the
fiscal year ended May 31, 2022, an increase of 27.8%. The increase in net sales for the fiscal year ended May 31, 2023
was primarily due to the increases in net sales of our wafer-level test products. Net sales of our wafer-level test products
for fiscal 2023 were $63.5 million and increased approximately $14.6 million from fiscal 2022 due to strong demand for
our FOX-P systems.
GROSS PROFIT. Gross profit increased to $32.7 million for the fiscal year ended May 31, 2023 from $23.7 million
for the fiscal year ended May 31, 2022, an increase of 38.4%. Gross margin increased to 50.4% for the fiscal year ended
May 31, 2023 from 46.6% for the fiscal year ended May 31, 2022. The increase in gross margin was primarily the result
of a decrease in other cost of sales of 1.6 percentage points primarily due to lower costs of provision for inventory
reserves, a decrease in labor and overhead of 1.2 percentage points due to manufacturing efficiencies due to higher sales
volume, and a benefit of 1.0 percentage points due to lower direct material costs.
SELLING, GENERAL AND ADMINISTRATIVE. SG&A expenses were $12.2 million for the fiscal year ended
May 31, 2023, compared with $10.0 million for the fiscal year ended May 31, 2022, an increase of 21.8%. The increase
in SG&A expenses was primarily the result of increased shareholder relation costs of $0.5 million, recruiting and
relocation of $0.3 million, and employment-related expenses of $0.3 million to support our growing business.
RESEARCH AND DEVELOPMENT. R&D expenses were $7.1 million for the fiscal year ended May 31, 2023,
compared with $5.8 million for the fiscal year ended May 31, 2022, an increase of 22.6%. The increase in R&D expenses
was primarily due to increases in project expenses of $0.6 million and employment-related expenses of $0.5 million
related to R&D initiatives during fiscal 2023.
INTEREST INCOME (EXPENSE), NET. Interest income, net was $1.2 million and $13,000 for the fiscal years
ended May 31, 2023 and 2022, respectively. Higher interest income for the fiscal year ended May 31, 2023 was driven by
higher cash deposits and higher interest rates in fiscal year ended May 31, 2023.
GAIN FROM FORGIVENESS OF PPP LOAN. On June 12, 2021, we received confirmation from SVB that on
June 4, 2021, the Small Business Administration approved our Payroll Protection Program loan (“PPP Loan”)
forgiveness application for the entire PPP Loan balance of $1,679,000 and interest totaling $19,000, and we recognized a
gain of $1,698,000.
OTHER (EXPENSE) INCOME, NET. Other expense, net was $3,000 for the fiscal year ended May 31, 2023,
compared with other income, net of $30,000 for the fiscal year ended May 31, 2022. The change in other (expense)
income, net was primarily due to losses or gains realized in connection with the fluctuation in the value of the dollar
compared to foreign currencies during the referenced periods.
INCOME TAX (EXPENSE) BENEFIT. Income tax expense was $60,000 and $91,000 for the fiscal years ended
May 31, 2023 and 2022, respectively. Income tax expense for both fiscal years were related to income taxes incurred in
foreign tax jurisdictions. Income tax expense was not significant due to available net operating loss and research and
development credit carryforwards.
FISCAL YEAR ENDED MAY 31, 2022 COMPARED TO FISCAL YEAR ENDED MAY 31, 2021
NET SALES. Net sales increased to $50.8 million for the fiscal year ended May 31, 2022 from $16.6 million for the
fiscal year ended May 31, 2021, an increase of 206.2%. The increase in net sales for the fiscal year ended May 31, 2022
was primarily due to the increases in net sales of our wafer-level products. Net sales of our wafer-level products for
fiscal 2022 were $48.9 million, and increased approximately $33.9 million from fiscal 2021 due to stronger demand
related to silicon carbide applications.
GROSS PROFIT. Gross profit increased to $23.7 million for the fiscal year ended May 31, 2022 from $6.0 million
for the fiscal year ended May 31, 2021, an increase of 292.3%. Gross profit margin increased to 46.6% for the fiscal year
ended May 31, 2022 from 36.3% for the fiscal year ended May 31, 2021. The increase in gross profit margin was
primarily the result of manufacturing efficiencies due to an increase in net sales.
SELLING, GENERAL AND ADMINISTRATIVE. SG&A expenses were $10.0 million for the fiscal year ended
May 31, 2022, compared with $6.6 million for the fiscal year ended May 31, 2021, an increase of 53.1%. The increase in
SG&A expenses was primarily the result of increased bonuses, stock-based compensation, and commission expense due
to an increase in net sales and profitability, and an increase in headcount.
22
RESEARCH AND DEVELOPMENT. R&D expenses were $5.8 million for the fiscal year ended May 31, 2022,
compared with $3.7 million for the fiscal year ended May 31, 2021, an increase of 59.3%. The increase in R&D expenses
was primarily due to increases in employment-related expenses of $1.7 million, outside services of $316,000, and project
expenses of $155,000. The increase in employment-related expenses was primarily the result of increased bonuses and
stock-based compensation due to an increase in net sales and profitability, and an increase in headcount.
INTEREST INCOME (EXPENSE), NET. Interest income, net was $13,000 for the fiscal year ended May 31, 2022,
compared with interest expense of $46,000 for the fiscal year ended May 31, 2021. The interest expense for the fiscal
year ended May 31, 2021 was from the PPP Loan that we obtained on April 23, 2020.
NET GAIN FROM DISSOLUTION OF AEHR TEST SYSTEMS JAPAN. Net gain from dissolution of Aehr Test
Systems Japan was $2.2 million for the fiscal year ended May 31, 2021, due to the release of the cumulative translation
adjustment in connection with the complete liquidation of Aehr Test Systems Japan subsidiary in July 2020.
GAIN FROM FORGIVENESS OF PPP LOAN. On June 12, 2021, we received confirmation from SVB that on
June 4, 2021, the Small Business Administration approved our PPP Loan forgiveness application for the entire PPP
Loan balance of $1,679,000 and interest totaling $19,000, and we recognized a gain of $1,698,000.
OTHER (EXPENSE) INCOME, NET. Other income, net was $30,000 for the fiscal year ended May 31, 2022,
compared with other expense, net of $162,000 for the fiscal year ended May 31, 2021. The change in other (expense)
income, net was primarily due to gains or losses realized in connection with the fluctuation in the value of the dollar
compared to foreign currencies during the referenced periods.
INCOME TAX (EXPENSE) BENEFIT. Income tax expense for the fiscal year ended May 31, 2022 was $91,000
compared with income tax benefit of $177,000 for the fiscal year ended May 31, 2021. During the fiscal year ended May
31, 2021, the currency translation adjustment balance was released and the residual income tax effect of $215,000 was
recorded pursuant to the inter-period allocation rules in connection with the complete liquidation of Aehr Test Systems
Japan subsidiary in July 2020.
LIQUIDITY AND CAPITAL RESOURCES
We consider cash, cash equivalents and short-term investments as liquid and available for use. As of May 31, 2023
and 2022, respectively, we had $30.2 million and $31.6 million in cash, cash equivalents and restricted cash. We also had
$17.9 million in short-term investments as of May 31, 2023.
Net cash provided by operating activities was $10.0 million and $1.5 million for the fiscal year ended May 31, 2023
and 2022, respectively. For the fiscal year ended May 31, 2023, net cash provided by operating activities was primarily
the result of net income of $14.6 million, net of a non-cash charge of stock-based compensation expense of $2.7 million,
depreciation and amortization of $0.5 million, and accretion of investment discount of $0.6 million. Other changes in
cash from operations primarily resulted from increases in inventories and trade and other accounts receivable of $9.5
million and $3.8 million, respectively, partially offset by increases in accounts payable, accrued expenses and customer
deposits and deferred revenue of $5.0 million, $0.5 million and $0.4 million, respectively. The increase in inventory was
to support expected future shipments for customer orders. The increase in trade and other accounts receivable was
primarily due to higher revenues and lower customer deposits on shipments. The increase in accounts payable was
primarily due to inventory purchases to support future shipments. For the fiscal year ended May 31, 2022, net cash
provided by operating activities was primarily the result of net income of $9.5 million, as adjusted to exclude the effect
of forgiveness of PPP loan of $1.7 million, and a non-cash charge of stock-based compensation expense of $3.0 million
and depreciation and amortization of $356,000. Other changes in cash from operations primarily resulted from
increases in accounts receivable and inventories of $7.8 million and $6.7 million, respectively, partially offset by increases
in customer deposits and deferred revenue, accrued expenses, and accounts payable of $2.2 million, $1.5 million and $1.4
million, respectively. The increase in accounts receivable was primarily due to the increase in and timing of revenue
generated toward the end of the fiscal year ended May 31, 2022. The increase in inventory was to support expected
future shipments for customer orders. The increase in customer deposits and deferred revenue was primarily due to the
receipt of additional down payments from certain customers. The increase in accrued expenses was primarily due to an
increase in accrued employment related expenses including profit sharing, commissions, bonuses, and vacations. The
increase in accounts payable was primarily due to inventory purchases to support future shipments.
Net cash used in investing activities was $18.7 million and $0.4 million for the fiscal years ended May 31, 2023 and
2022, respectively. During the fiscal year ended May 31, 2023, net cash used in investing activities was due to the
purchases of U.S. treasury securities of $33.3 million, partially offset by proceeds from maturities of U.S. treasury
securities of $16 million, and the purchases of property and equipment of $1.4 million. During the fiscal year ended May
31, 2022, net cash used in investing activities was due to purchases of property and equipment.
23
Financing activities provided cash of $7.3 million and $25.8 million for the fiscal years ended May 31, 2023 and 2022,
respectively. Net cash provided by financing activities during the fiscal year ended May 31, 2023 was primarily due to
the net proceeds from issuance of common stock from public offering of $6.8 million, and the proceeds from the
issuance of common stock under employee benefit plans of $2.6 million, partially offset by the shares repurchased for
tax withholdings on vesting of RSUs and PRSUs of $2.1 million. Net cash provided by financing activities during the
fiscal year ended May 31, 2022 was primarily due to the net proceeds from issuance of common stock from public
offering of $24.0 million, and the proceeds from the issuance of common stock under employee benefit plans of $3.6
million, partially offset by the shares repurchased for tax withholdings on vesting of RSUs of $0.4 million, and by the net
payment of the line of credit of $1.4 million.
The effect of fluctuation in exchange rates decreased cash by $37,000 for the fiscal years ended May 31, 2023 and
increased cash by $49,000 for the fiscal years ended May 31, 2022. The changes were due to the fluctuation in the value
of the dollar compared to foreign currencies.
As of May 31, 2023 and 2022, we had working capital of $72.7 million and $49.0 million, respectively.
For the fiscal year ended May 31, 2021, net cash used in operating activities was primarily the result of the net loss of
$2.0 million, as adjusted to exclude the effect of net gain from dissolution of Aehr Test Systems Japan of $2.4 million,
including an income tax benefit of $215,000, a non-cash charge for stock-based compensation expense of $1.1 million
and depreciation and amortization of $328,000. Net cash used in operations was also impacted by increases in accounts
receivable and inventories of $1.4 million and $972,000, respectively, partially offset by increases in accounts payable and
accrued expenses of $1.9 million and $732,000, respectively. The increase in accounts receivable was primarily due to
higher shipment activities toward the end of fiscal year ended May 31, 2021. The increase in inventory was to support
expected future shipments for customer orders. The increase in accounts payable was primarily due to inventory
purchases to support future shipments. The increase in accrued expenses was primarily due to increases in warranty
provision and accrued employment related expenses.
Net cash used in investing activities was $227,000 for the fiscal year ended May 31, 2021 was due to the purchase of
property and equipment.
Net cash provided by financing activities was $2.0 million for the fiscal year ended May 31, 2021 was due to $1.4
million borrowing from our line of credit and $560,000 in proceeds from the issuance of common stock under employee
plans.
The effect of fluctuation in exchange rates increased cash by $117,000 for the fiscal year ended May 31, 2021 due to
the fluctuation in the value of the dollar compared to foreign currencies.
We lease our manufacturing and office space under operating leases. We entered into a non-cancelable operating
lease agreement for our United States manufacturing and office facilities, which was renewed in December 2022 and
expires in September 2030. As of May 31, 2023 our operating lease liabilities totaled $6,300,000. Under that lease
agreement, we are responsible for payments of utilities, taxes and insurance.
From time to time, we evaluate potential acquisitions of businesses, products or technologies that complement our
business. If consummated, any such transactions may use a portion of our working capital or require the issuance of
equity. We have no present understandings, commitments or agreements with respect to any material acquisitions.
We anticipate that the existing cash balance and the available line of credit together with future income from
operations, collections of existing accounts receivable, revenue from our existing backlog of products as of this filing
date, the sale of inventory on hand, deposits and down payments against significant orders will be adequate to meet our
working capital and capital equipment requirement needs over the next 12 months. Our future capital requirements will
depend on many factors, including our growth rate, the timing and extent of our spending to support research and
development activities, the timing and cost of establishing additional sales and marketing capabilities, the timing and cost
to introduce new and enhanced products and the timing and cost to implement new manufacturing technologies. We
successfully raised $25 million in an at-the-market (“ATM”) offering in October 2021 and $7.3 million in a follow on
ATM offering in February 2023; however, in the event that additional financing is required from outside sources, we
may not be able to raise it on terms acceptable to us or at all. Any additional debt financing obtained by us in the future
could also involve restrictive covenants relating to our capital-raising activities and other financial and operational
matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities,
including potential acquisitions. Additionally, if we raise additional funds through further issuances of equity,
convertible debt securities or other securities convertible into equity, our existing stockholders could suffer significant
dilution in their percentage ownership of the Company, and any new equity securities we issue could have rights,
preferences and privileges senior to those of holders of our common stock. If we are unable to obtain adequate
24
financing or financing on terms satisfactory to us when we require it, our ability to continue to grow or support our
business and to respond to business challenges could be significantly limited.
OFF-BALANCE SHEET FINANCING
We have not entered into any off-balance sheet financing arrangements and have not established any special purpose
or variable interest entities.
OVERVIEW OF CONTRACTUAL OBLIGATIONS
The following table provides a summary of such arrangements, or contractual obligations.
Lease obligations
Purchases (1)
Total
Total
$ 8,429
26,318
$34,747
Payments Due by Period (in thousands)
Less than
1 year
$
608
26,318
$26,926
1-3
years
$2,317
--
$2,317
4-5
years
$2,429
--
$2,429
More than
5 years
$3,075
--
$3,075
(1) Shown above are our binding purchase obligations. The large majority of our purchase orders are cancelable by either
party, which if canceled may result in a negotiation with the vendor to determine if there shall be any restocking or
cancellation fees payable to the vendor.
In the normal course of business to facilitate sales of our products, we indemnify other parties, including customers,
with respect to certain matters. We have agreed to hold the other party harmless against losses arising from a breach of
representations or covenants, or from intellectual property infringement or other claims. These agreements may limit
the time period within which an indemnification claim can be made and the amount of the claim. In addition, we have
entered into indemnification agreements with our officers and directors, and our bylaws contain similar indemnification
obligations to our agents.
It is not possible to determine the maximum potential amount under these indemnification agreements due to the
limited history of prior indemnification claims and the unique facts and circumstances involved in each particular
agreement. To date, our payments under these agreements have not had a material impact on our operating results,
financial position or cash flows.
RECENT ACCOUNTING PRONOUNCEMENTS
For a description of recent accounting pronouncements, including the expected dates of adoption and estimated
effects, if any, on our consolidated financial statements, see Note 1, “Organization and Summary of Significant
Accounting Policies,” of the Notes to Consolidated Financial Statements.
Item 7A. Quantitative and Qualitative Disclosures about Market Risk
As a Smaller Reporting Company, we are not required to provide information under Item 7A.
25
Item 8. Financial Statements and Supplementary Data
INDEX
Consolidated Financial Statements of Aehr Test Systems
Report of Independent Registered Public Accounting Firm (Firm ID 207) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .27
Consolidated Balance Sheets at May 31, 2023 and 2022. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Consolidated Statements of Operations for the years ended May 31, 2023, 2022 and 2021. . . . . . . . . . . . . . . . . . .30
Consolidated Statements of Comprehensive Income (Loss) for the years ended May 31, 2023, 2022 and 2021 . . .31
Consolidated Statements of Shareholders' Equity for the years ended May 31, 2023, 2022 and 2021 . . . . . . . . . . .32
Consolidated Statements of Cash Flows for the years ended May 31, 2023, 2022 and 2021. . . . . . . . . . . . . . . . . . 33
Notes to Consolidated Financial Statements. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Financial statement schedules not listed above are either omitted because they are not applicable or the required
information is shown in the Consolidated Financial Statements or in the Notes thereto.
26
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors of
Aehr Test Systems
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated balance sheets of Aehr Test Systems and its subsidiaries (the “Company”)
as of May 31, 2023 and 2022, the related consolidated statements of operations, comprehensive income (loss),
shareholders’ equity, and cash flows for each of the three years in the period ended May 31, 2023, and the related notes
(collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of the Company as of May 31, 2023 and 2022, and the results
of its operations and its cash flows for each of the three years in the period ended May 31, 2023, in conformity with
accounting principles generally accepted in the United States of America.
Basis for Opinion
These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to
express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting
firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be
independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of
internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the
Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by
management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our
audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial
statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts
or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging,
subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion
on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter
below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which it relates.
Inventory Valuation – Adjustments for Excess or Obsolete Inventory
As described in Note 1 to the consolidated financial statements, the Company’s consolidated inventories balance was $23.9
million as of May 31, 2023. The Company’s inventory is stated at the lower of cost, which is determined on a standard
cost basis on a first-in, first-out method, or net realizable value. The Company evaluates the net realizable value by
considering obsolescence, excessive levels of inventory, deterioration and other factors. Adjustments to reduce the cost of
inventory to its net realizable value, if required, are made for estimated excess, obsolescence or impaired inventory. If
actual demand were to be substantially lower than estimated, there could be a significant adverse impact on the carrying
value of the inventory and results of operations.
The principal considerations for our determination that performing procedures relating to adjustments for excess or
obsolete inventory is a critical audit matter are the significant amount of judgement by management in developing the
assumptions of the forecasted product demand, which in turn led to significant auditor judgement, subjectivity, and effort
in performing audit procedures and evaluating audit evidence relating to the forecasted product demand. Additionally, for
certain new sales channels there may be limited historical data with which to evaluate forecasts.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our
overall opinion on the consolidated financial statements. These procedures included, among others, testing management’s
27
process for developing the estimate of the adjustments for excess or obsolete inventory, testing the completeness and
accuracy of the underlying data used in the estimate, and evaluating management’s assumptions of forecasted product
demand. Evaluating management’s demand forecast for reasonableness involved considering historical sales of its
products, comparing prior period estimates to actual results of the same period, and determining whether the demand
forecast used was consistent with evidence obtained in other areas of the audit.
/s/ BPM LLP
We have served as the Company’s auditor since 2005.
San Jose, California
August 28, 2023
28
AEHR TEST SYSTEMS AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
ASSETS
Current assets:
Cash and cash equivalents. . . . . . . . . . . . . . . . . . . . . . . .
Short-term investments. . . . . . . . . . . . . . . . . . . . . . . . . .
Trade and other accounts receivable, net. . . . . . . . . . . . .
Inventories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other current assets. . . . . . . . . . . .
May 31,
2023
2022
$30,054
17,853
16,594
23,908
621
$31,484
--
12,859
15,051
613
Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . .
89,030
60,007
Property and equipment, net. . . . . . . . . . . . . . . . . . . . . . .
Operating lease right-of-use assets . . . . . . . . . . . . . . . . . .
Other assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2,759
6,123
231
1,203
917
201
Total assets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$98,143
$62,328
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating lease liabilities, short-term. . . . . . . . . . . . . . . .
Customer deposits and deferred revenue, short-term . . .
$9,206
4,143
137
2,822
$4,195
3,610
794
2,415
Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . .
16,308
11,014
Operating lease liabilities, long-term . . . . . . . . . . . . . . . . .
Deferred revenue, long-term . . . . . . . . . . . . . . . . . . . . . . .
Other long-term liabilities. . . . . . . . . . . . . . . . . . . . . . . . . .
6,163
31
41
212
69
44
Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22,543
11,339
Commitments and contingencies (Note 20)
Shareholders' equity:
Preferred stock, $0.01 par value: Authorized: 10,000 shares;
Issued and outstanding: none . . . . . . . . . . . . . . . . . . . .
Common stock, $0.01 par value: Authorized: 75,000 shares;
Issued and outstanding: 28,539 shares and 27,120
shares at May 31, 2023 and 2022 respectively . . . . . . .
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . .
Accumulated deficit. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total shareholders' equity . . . . . . . . . . . . . . . . . . . . . . .
--
--
285
127,776
(155)
(52,306)
75,600
271
117,686
(105)
(66,863)
50,989
Total liabilities and shareholders' equity . . . . . . . . . . .
$98,143
$62,328
The accompanying notes are an integral part of these consolidated financial statements.
29
AEHR TEST SYSTEMS AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE DATA)
Net sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cost of sales . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Gross profit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:
Selling, general and administrative . . . . . . . . . . . . . . . . . .
Research and development. . . . . . . . . . . . . . . . . . . . . . . .
2023
$64,961
32,215
32,746
Year Ended May 31,
2022
2021
$50,829
27,164
23,665
$16,600
10,568
6,032
12,237
7,134
10,047
5,818
6,562
3,652
Total operating expenses . . . . . . . . . . . . . . . . . . . . . . . .
19,371
15,865
10,214
Income (loss) from operations . . . . . . . . . . . . . . . . . . . . . .
13,375
7,800
(4,182)
Interest income (expense), net. . . . . . . . . . . . . . . . . . . . . . .
Net gain from dissolution of Aehr Test Systems Japan. . . .
Gain from forgiveness of PPP loan. . . . . . . . . . . . . . . . . . .
Other (expense) income, net . . . . . . . . . . . . . . . . . . . . . . . .
1,245
--
--
(3)
13
--
1,698
30
(46)
2,186
--
(162)
Income (loss) before income tax (expense) benefit . . . . . . .
14,617
9,541
(2,204)
Income tax (expense) benefit. . . . . . . . . . . . . . . . . . . . . . . .
(60)
(91)
177
Net income (loss). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$14,557
$ 9,450
$(2,027)
Earnings (net loss) per share – basic. . . . . . . . . . . . . . . . . . . .
Earnings (net loss) per share – diluted . . . . . . . . . . . . . . . . . .
Shares used in per share calculation – basic. . . . . . . . . . . . . .
Shares used in per share calculation – diluted . . . . . . . . . . . .
$ 0.52
$ 0.50
27,785
29,215
$ 0.36
$ 0.34
26,014
27,774
$ (0.09)
$ (0.09)
23,457
23,457
The accompanying notes are an integral part of these consolidated financial statements.
30
AEHR TEST SYSTEMS AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(IN THOUSANDS)
2023
Year Ended May 31,
2022
2021
Net income (loss). . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
$14,557
$ 9,450
$(2,027)
Other comprehensive income (loss), net of tax:
Foreign currency translation (loss) income . . . . . . . .
Net change in unrealized loss on investments. . . . . .
Reclassification of cumulative
translation adjustment as a result of
dissolution of Aehr Test Systems Japan. . . . . . . .
(33)
(17)
(77)
--
160
--
--
--
(2,401)
Total comprehensive income (loss). . . . . . . . . . . . . . . .
14,507
9,373
(4,268)
Less: Comprehensive income attributable to
noncontrolling interest . . . . . . . . . . . . . . . . . . . . .
--
--
Comprehensive income (loss). . . . . . . . . . . . . . . . . . . .
$14,507
$ 9,373
21
$(4,289)
The accompanying notes are an integral part of these consolidated financial statements.
31
AEHR TEST SYSTEMS AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(IN THOUSANDS)
Accumulated
Additional
Other
Total Aehr
Test
Systems
Total
Common Stock
Paid-in
Comprehensive
Accumulated
Shareholders’
Noncontrolling
Shareholders'
Shares
23,107
Amount
$231
Capital
Income (loss)
$85,898
$2,234
Deficit
$(74,286)
Equity
$ 14,077
Interest
Equity
$(21) $ 14,056
Balances, May 31, 2020
Issuance of common stock
under employee plans . . . . . . .
627
6
574
--
--
580
Shares repurchased for tax
--
withholdings on vesting of RSUs (9)
Stock-based compensation. . . . . . -- --
--
--
(20)
1,101
--
--
--
--
--
--
(2,027)
(20)
1,101
(2,027)
--
--
--
--
580
(20)
1,101
(2,027)
Net loss . . . . . . . . . . . . . . . . . . . . .
Reclassification of cumulative
translation adjustment. . . . . . .
-- --
--
(2,401)
--
(2,401)
-- (2,401)
--
Foreign currency
translation adjustment . . . . . . .
--
--
--
139
--
139
21
160
Balances, May 31, 2021
23,725
237
87,553
(28)
(76,313)
11,449
--
11,449
Issuance of common stock
under employee plans. . . . . . .
1,760
17
3,543
Shares repurchased for tax
withholdings on vesting of RSUs
(62)
--
(429)
--
--
--
3,560
--
3,560
--
(429)
--
(429)
Proceeds from public offerings,
net of issuance costs. . . . . . . . .
Stock-based compensation. . . . . . .
Net income . . . . . . . . . . . . . . . . . . .
Foreign currency
1,697 17
--
--
--
--
24,013
3,006
--
--
--
--
9,450
--
--
24,030
3,006
9,450
-- 24,030
3,006
9,450
--
--
--
translation adjustment. . . . . . . .
--
--
--
(77)
--
(77)
--
(77)
Balances, May 31, 2022 27,120
271
117,686
(105)
(66,863)
50,989
--
50,989
Issuance of common stock
under employee plans. . . . . . . .
Shares repurchased for tax
withholdings on vesting of RSUs
Proceeds from public offerings,
net of issuance costs. . . . . . . . .
Stock-based compensation. . . . . . .
Net income . . . . . . . . . . . . . . . . . . .
Net unrealized loss on investments
Foreign currency
1,388
13
2,549
--
--
2,562
--
2,562
(178)
(1)
(2,059)
--
--
(2,060)
--
(2,060)
209
--
--
--
2
--
--
--
--
6,818
2,782
--
--
--
--
--
(17)
--
--
14,557
--
6,820
2,782
14,557
(17)
--
--
--
--
6,820
2,782
14,557
(17)
--
(33)
--
(33)
--
(33)
translation adjustment. . . . . . . . .
--
Balances, May 31, 2023
28,539
$285
$127,776
$ (155)
$(52,306)
$75,600
$ --
$75,600
The accompanying notes are an integral part of these consolidated financial statements.
32
AEHR TEST SYSTEMS AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
Cash flows from operating activities:
Net income (loss) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . .
Provision for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . .
Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . .
Non-cash operating lease expense. . . . . . . . . . . . . . . . . . . . . .
Accretion of investment discount . . . . . . . . . . . . . . . . . . . . . .
Net gain from dissolution of Aehr Test Systems Japan. . . . . .
Income tax benefit related to dissolution of
Aehr Test Systems Japan. . . . . . . . . . . . . . . . . . . . . . . . . . .
Gain from forgiveness of PPP loan. . . . . . . . . . . . . . . . . . . . .
Changes in operating assets and liabilities:
Trade and other accounts receivable . . . . . . . . . . . . . . . . . . .
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid expenses and other. . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts payable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Customer deposits and deferred revenue. . . . . . . . . . . . . . . .
Other long-term liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes payable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net cash provided by (used in) operating activities. . . . . . .
Cash flows from investing activities:
Purchases of investments . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from maturities of investments . . . . . . . . . . . . . . . . .
Purchases of property and equipment. . . . . . . . . . . . . . . . . . . .
Net cash used in investing activities . . . . . . . . . . . . . . . . . . .
Cash flows from financing activities:
Line of credit (repayments) borrowings, net . . . . . . . . . . . . . . .
Proceeds from issuance of common stock
under employee plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Shares repurchased for tax withholdings on vesting
of restricted stock units. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from issuance of common stock
from public offering, net of issuance costs. . . . . . . . . . . . . . . .
Net cash provided by financing activities. . . . . . . . . . . . . . . .
Effect of exchange rates on cash, cash equivalents and
restricted cash. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
Year Ended May 31,
2022
2021
$14,557
$ 9,450
$(2,027)
2,748
24
450
88
(576)
--
--
--
(3,788)
(9,469)
28
5,044
528
369
--
8
10,011
(33,294)
16,000
(1,362)
(18,656)
3,006
--
356
(49)
--
--
--
(1,698)
(7,834)
(6,674)
(71)
1,356
1,464
2,196
--
6
1,508
--
--
(416)
(416)
1,101
--
328
(18)
--
(2,186)
(215)
--
(1,373)
(972)
(81)
1,877
732
96
47
(10)
(2,701)
--
--
(227)
(227)
--
(1,400)
1,400
2,562
3,560
580
(2,060)
(429)
(20)
6,820
7,322
24,030
25,761
--
1,960
(37)
49
117
Net (decrease) increase in cash, cash equivalents and
restricted cash. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash, cash equivalents and restricted cash, beginning of year. . . . .
(1,360)
31,564
Cash, cash equivalents and restricted cash, end of year. . . . . . . . . .
$30,204
26,902
4,662
$31,564
(851)
5,513
$ 4,662
Supplemental cash flow information:
Cash paid during the year for:
Income taxes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Supplemental disclosure of non-cash flow information:
Net transfer of equipment between inventory
and property and equipment. . . . . . . . . . . . . . . . . . . . . . . . .
$ 21
$ 15
$ 4
$ 12
$ 15
$ 6
$646
$ 472
$ 113
The accompanying notes are an integral part of these consolidated financial statements.
33
AEHR TEST SYSTEMS AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:
BUSINESS:
Aehr Test Systems (the “Company”) was incorporated in California in May 1977 and primarily designs, engineers and
manufactures test and burn-in equipment used in the semiconductor industry. The Company’s principal products are
the FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer
contactor, the DiePak carrier, the WaferPak aligner, the DiePak autoloader, and test fixtures.
CONSOLIDATION:
The consolidated financial statements include the accounts of the Company and both its wholly-owned and majority-
owned foreign subsidiaries. Intercompany accounts and transactions have been eliminated.
FOREIGN CURRENCY TRANSLATION AND TRANSACTIONS:
Assets and liabilities of the Company’s foreign subsidiaries and a branch office are translated into U.S. Dollars from
their functional currencies of Euros, Philippines Peso and New Taiwan Dollars using the exchange rate in effect at the
balance sheet date. Additionally, their net sales and expenses are translated using exchange rates approximating average
rates prevailing during the fiscal year. Translation adjustments that arise from translating their financial statements from
their local currencies to U.S. Dollars are accumulated and reflected as a separate component of shareholders’ equity.
Transaction gains and losses that arise from exchange rate changes denominated in currencies other than the local
currency are included in the Consolidated Statements of Operations as incurred. See Note 15, “Other (Expense)
Income, Net” for the detail of foreign exchange transaction gains and losses for all periods presented.
USE OF ESTIMATES:
The preparation of financial statements in conformity with accounting principles generally accepted in the United
States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those
estimates. Significant estimates in the Company’s consolidated financial statements include allowance for doubtful
accounts, valuation of inventory at the lower of cost or net realizable value, and warranty reserves.
RECLASSIFICATIONS:
Certain reclassifications have been made to the previous year consolidated financial statements to conform to the
current period presentation. The reclassifications had no impact on net income (loss), total assets, total liabilities, or
shareholders’ equity.
CASH EQUIVALENTS:
Cash equivalents consist of money market instruments purchased with an original maturity of three months or less.
These investments are reported at fair value.
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS:
Accounts receivable are derived from the sale of products throughout the world to semiconductor manufacturers,
semiconductor contract assemblers, electronics manufacturers and burn-in and test service companies. Accounts
receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for
doubtful accounts to reserve for potentially uncollectible trade receivables. The Company also reviews its trade
receivables by aging category to identify specific customers with known disputes or collection issues. The Company
exercises judgment when determining the adequacy of these reserves as the Company evaluates historical bad debt
trends, general economic conditions in the United States and internationally, and changes in customer financial
conditions. Uncollectible receivables are recorded as bad debt expense when all efforts to collect have been exhausted
and recoveries are recognized when they are received. During the fiscal year ended May 31, 2023, the Company recorded
bad debt expense of $24,000. No significant adjustments to the allowance for doubtful accounts were recorded during
the fiscal years ended May 31, 2022 or 2021.
34
CONCENTRATION OF CREDIT RISK:
The Company sells its products primarily to semiconductor manufacturers in North America, Asia, and Europe. As
of May 31, 2023, approximately 17% and 83% of gross accounts receivable were from customers located in North
America and Asia, respectively. As of May 31, 2022, approximately 20% and 80% of gross accounts receivable were
from customers located in North America and Asia, respectively. Two customers accounted for 82% and 17% of gross
accounts receivable as of May 31, 2023. Three customers accounted for 68%, 18% and 11% of gross accounts
receivable as of May 31, 2022. Two customers accounted for 79% and 10% of net sales in fiscal 2023, respectively. One
customer accounted for 82% of net sales in fiscal 2022. The Company performs ongoing credit evaluations of its
customers and generally does not require collateral. The Company uses letter of credit terms for some of its
international customers.
The Company’s cash and cash equivalents are generally deposited with major financial institutions in the United
States, Philippines, Germany and Taiwan. The Company invests its excess cash in money market funds and U.S.
Treasury securities. The money market funds bear the risk associated with each fund. The money market funds have
variable interest rates. The Company’s cash and investment balances held at banks and brokerage firms may at time
exceed federally insured levels. The Company has not experienced any material losses on its money market funds or
short-term cash deposits.
CONCENTRATION OF SUPPLY RISK:
The Company relies on subcontractors to manufacture many of the components and subassemblies used in its
products. Quality or performance failures of the Company’s products or changes in its manufacturers’ financial or
business condition could disrupt the Company’s ability to supply quality products to its customers and thereby have a
material and adverse effect on its business and operating results. Some of the components and technologies used in the
Company’s products are purchased and licensed from a single source or a limited number of sources. The loss of any of
these suppliers may cause the Company to incur additional transition costs, result in delays in the manufacturing and
delivery of its products, or cause it to carry excess or obsolete inventory and could cause it to redesign its products.
INVENTORIES:
Inventories include material, labor and overhead, and are stated at the lower of cost (first-in, first-out method) or net
realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less costs of
completion, disposal and transportation. Provisions for excess, obsolete and unusable inventories are made after
management’s evaluation of future demand and market conditions. The Company adjusts inventory balances to
approximate the lower of its manufacturing costs or net realizable value. If actual future demand or market conditions
become less favorable than those projected by management, additional inventory write-downs may be required, and
would be reflected in cost of sales in the period the revision is made. During fiscal 2023, 2022 and 2021 the Company
recognized a provision for inventory reserves of $569,000, $1,031,000, and $176,000, respectively.
PROPERTY AND EQUIPMENT:
Property and equipment are stated at cost less accumulated depreciation and amortization. Major improvements are
capitalized, while repairs and maintenance are expensed as incurred. Leasehold improvements are amortized over the
lesser of their estimated useful lives or the term of the related lease. Furniture and fixtures, machinery and equipment,
and test equipment are depreciated on a straight-line basis over their estimated useful lives. The ranges of estimated
useful lives are generally as follows:
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 to 6 years
Machinery and equipment. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 to 6 years
Test equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 to 6 years
REVENUE RECOGNITION:
The Company recognizes revenue when promised goods or services are transferred to customers in an amount that
reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by
following a five-step process: (1) identify the contract with a customer, (2) identify the performance obligations in the
contract, (3) determine the transaction price, (4) allocate the transaction price, and (5) recognize revenue when or as the
Company satisfies a performance obligation, as further described below.
Performance obligations include sales of systems, contactors, spare parts, and services, as well as installation and
training services included in customer contracts.
35
A contract’s transaction price is allocated to each distinct performance obligation. In determining the transaction
price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to
which the Company expects to be entitled. The Company generally does not grant return privileges, except for defective
products during the warranty period.
For contracts that contain multiple performance obligations, the Company allocates the transaction price to the
performance obligations on a relative standalone selling price basis. Standalone selling prices are based on multiple
factors including, but not limited to, historical discounting trends for products and services and pricing practices in
different geographies.
Revenue for systems and spares are recognized at a point in time, which is generally upon shipment or delivery.
Revenue from services is recognized over time as services are completed or ratably over the contractual period of
generally one year or less.
The Company has elected the practical expedient to not assess whether a contract has a significant financing
component as the Company’s standard payment terms are less than one year.
We sell our products primarily through a direct sales force. In certain international markets, we sell our products
through independent distributors.
Transfer of control is evidenced upon passage of title and risk of loss to the customer unless we are required to
provide additional services.
PRODUCT DEVELOPMENT COSTS AND CAPITALIZED SOFTWARE:
Costs incurred in the research and development of new products or systems are charged to operations as incurred.
Costs incurred in the development of software programs for the Company’s products are charged to operations as
incurred until technological feasibility of the software has been established. Generally, technological feasibility is
established when the software module performs its primary functions described in its original specifications, contains
features required for it to be usable in a production environment, is completely documented and the related hardware
portion of the product is complete. After technological feasibility is established, any additional costs are capitalized.
Capitalization of software costs ceases when the software is substantially complete and is ready for its intended use.
Capitalized costs are amortized over the estimated life of the related software product using the greater of the units of
sales or straight-line methods over ten years. No system software development costs were capitalized or amortized in
fiscal 2023, 2022 and 2021.
IMPAIRMENT OF LONG-LIVED ASSETS:
In the event that facts and circumstances indicate that the carrying value of assets may be impaired, an evaluation of
recoverability would be performed. If an evaluation is required, the estimated future undiscounted cash flows associated
with the asset would be compared to the asset’s carrying value to determine if a write-down is required.
ADVERTISING COSTS:
The Company expenses all advertising costs as incurred and the amounts were not material for all periods presented.
SHIPPING AND HANDLING OF PRODUCTS:
Amounts billed to customers for shipping and handling of products are included in net sales. Costs incurred related
to shipping and handling of products are included in cost of sales.
INCOME TAXES:
Income taxes are accounted for under the asset-and-liability method as required by Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes (“ASC 740”). Deferred tax
assets and liabilities are recognized for the future tax consequences attributable to differences between the financial
statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax
credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable
income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period corresponding to the enactment
date. Under ASC 740, a valuation allowance is required when it is more likely than not all or some portion of the
deferred tax assets will not be realized through generating sufficient future taxable income.
36
As of May 31, 2023 the Company maintained a full valuation allowance against its deferred tax assets. We will
continue to assess whether sufficient future taxable income will be generated to permit the use of deferred tax assets, and
will reverse all or a portion of the allowance when there is sufficient evidence to support the reversal. Based upon our
prior two fiscal years of profitability, the outlook for the next fiscal year, and absent any additional objective negative
evidence, the Company anticipates adjusting the current valuation allowance position in fiscal 2024.
FASB ASC Subtopic 740-10, Accounting for Uncertainty of Income Taxes, (“ASC 740-10”) defines the criterion an
individual tax position must meet for any part of the benefit of the tax position to be recognized in financial statements
prepared in conformity with GAAP. The Company may recognize the tax benefit from an uncertain tax position only if
it is more likely than not such tax position will be sustained on examination by the taxing authorities, based solely on the
technical merits of the respective tax position. The tax benefits recognized in the financial statements from such a tax
position should be measured based on the largest benefit having a greater than 50% likelihood of being realized upon
ultimate settlement with the tax authority. In accordance with the disclosure requirements of ASC 740-10, the
Company’s policy on income statement classification of interest and penalties related to income tax obligations is to
include such items as part of income taxes.
COMPREHENSIVE INCOME (LOSS):
Comprehensive income (loss) generally represents all changes in shareholders’ equity except those resulting from
investments or contributions by shareholders. Unrealized gains and losses from available-for-sale securities and on
foreign currency translation adjustments are included in the Company’s components of comprehensive income (loss),
which are excluded from net income (loss). In fiscal 2021, the Company recognized a gain of $2,401,000 related to the
completed liquidation of ATS-Japan, a majority owned subsidiary, which is deducted from net income (loss) when
calculating comprehensive income (loss). Refer to Note 18, “Dissolution of Aehr Test Systems Japan,” for a further
discussion of the transaction. Comprehensive income (loss) is included in the statements of comprehensive income
(loss).
RECENT ACCOUNTING PRONOUNCEMENTS:
Accounting Standards Not Yet Adopted
In June 2016, the FASB issued Accounting Standard Update (“ASU”) 2016-13, Financial Instruments – Credit Losses
(Topic 326), that requires measurement and recognition of expected credit losses for financial assets held based on
historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the
reported amount. Due to a subsequent ASU in November 2019, the accounting standard will be effective for the
Company beginning in the first quarter of fiscal 2024 on a modified retrospective basis. The Company does not expect a
material impact of this accounting standard on its consolidated financial statements.
2. REVENUE:
Disaggregation of revenue
The following tables show revenues by major product categories. Within each product category, contract terms,
conditions and economic factors affecting the nature, amount, timing and uncertainty around revenue recognition and
cash flow are substantially similar.
The Company’s revenues by product category are as follows (in thousands):
Type of good / service:
Systems. . . . . . . . . . . . . . . . . . . .
Contactors . . . . . . . . . . . . . . . . .
Services . . . . . . . . . . . . . . . . . . .
Product lines:
Wafer-level. . . . . . . . . . . . . . . . .
Test During Burn-In. . . . . . . . .
Year Ended May 31,
2023
2022
2021
$38,844
21,873
4,244
$25,224
22,647
2,958
$ 7,250
5,837
3,513
$64,961
$50,829
$16,600
$63,531
1,430
$64,961
$48,926
1,903
$15,004
1,596
$50,829
$16,600
37
The following presents information about the Company’s operations in different geographic areas. Net sales are
based upon ship-to location (in thousands):
Geographic region:
United States . . . . . . . . . . . . . . .
Asia. . . . . . . . . . . . . . . . . . . . . . .
Europe . . . . . . . . . . . . . . . . . . . .
Year Ended May 31,
2023
2022
2021
$ 9,289
55,609
63
$64,961
$5,110
45,700
19
$ 5,386
11,074
140
$50,829
$16,600
With the exception of the amount of service contracts and extended warranties, the Company’s product category
revenues are recognized at point in time when control transfers to customers. The following presents revenue based on
timing of recognition (in thousands):
Timing of revenue recognition (in thousands):
Products and services transferred at
a point in time. . . . . . . . . . . . . . . . .
Services transferred over time . . . . . .
Contract balances
2023
Year Ended May 31,
2022
2021
$63,531
1,430
$64,961
$49,441
1,388
$50,829
$15,009
1,591
$16,600
A receivable is recognized in the period the Company delivers goods or provides services or when the Company’s
right to consideration is unconditional. The Company usually does not record contract assets because the Company has
an unconditional right to payment upon satisfaction of the performance obligation, and therefore, a receivable is more
commonly recorded than a contract asset.
Contract liabilities include payments received in advance of performance under a contract and are satisfied as the
associated revenue is recognized. Contract liabilities are reported on the consolidated balance sheets at the end of each
reporting period as a component of deferred revenue. Contract liabilities as of May 31, 2023 and 2022 were $2,853,000
and $2,484,000, respectively. During the fiscal years ended May 31, 2023 and 2022, the Company recognized $2,179,000
and $189,000 of revenues that were included in contract liabilities as of May 31, 2022 and 2021, respectively.
Remaining performance obligations
On May 31, 2023, the Company had $163,000 of remaining performance obligations, exclusive of customer deposits,
which were comprised of deferred service contracts and extended warranty contracts not yet delivered. The Company
expects to recognize approximately 81% of its remaining performance obligations as revenue in fiscal 2024, and an
additional 19% in fiscal 2025 and thereafter. The foregoing excludes the value of other remaining performance
obligations as they have original durations of one year or less, and also excludes information about variable consideration
allocated entirely to a wholly unsatisfied performance obligation.
Costs to obtain or fulfill a contract
The Company generally expenses sales commissions when incurred as a component of selling, general and
administrative expense as the amortization period is typically less than one year. Additionally, the majority of the
Company’s cost of fulfillment as a manufacturer of products is classified as inventory and fixed assets, which are
accounted for under the respective guidance for those asset types. Other costs of contract fulfillment are immaterial due
to the nature of the Company’s products and their respective manufacturing process.
3. EARNINGS PER SHARE (“EPS”):
Basic EPS is determined using the weighted average number of common shares outstanding during the period.
Diluted EPS is determined using the weighted average number of common shares and potential common shares
(representing the dilutive effect of stock options, restricted shares, restricted shares units, or RSUs, and ESPP shares)
outstanding during the period using the treasury stock method.
38
The following table presents the computation of basic and diluted earnings (net loss) per share attributable to Aehr
Test Systems common shareholders (in thousands, except per share data):
Numerator: Net income (net loss). . . . . . . . . . . . . . . . . . . . . .
Denominator for basic earnings (net loss) per share:
Weighted average shares outstanding . . . . . . . . . . . . . . . . . .
2023
$ 14,557
Year Ended May 31,
2022
$ 9,450
2021
$ (2,027)
27,785
26,014
23,457
Shares used in basic earnings (net loss) per share calculation . .
27,785
26,014
23,457
Effect of dilutive securities. . . . . . . . . . . . . . . . . . . . . . . . . . . .
1,430
1,760
--
Denominator for diluted earnings (net loss) per share . . . . . . .
29,215
27,774
23,457
Basic earnings (net loss) per share. . . . . . . . . . . . . . . . . . . . . . .
$ 0.52
$ 0.36
$ (0.09)
Diluted earnings (net loss) per share . . . . . . . . . . . . . . . . . . . . .
$ 0.50
$ 0.34
$ (0.09)
For the purpose of computing diluted earnings per share, weighted average potential common shares do not
include stock options with an exercise price greater than the average fair value of the Company’s common stock for the
period, as the effect would be anti-dilutive. Stock options to purchase 5,000 and 64,000 shares of common stock were
outstanding as of May 31, 2023 and 2022, respectively, but were not included in the computation of diluted earnings per
share, because the inclusion of such shares would be anti-dilutive. Stock options to purchase 2,766,000 shares of
common stock were outstanding on May 31, 2021 but were not included in the computation of diluted net loss per
share, because the inclusion of such shares would be anti-dilutive. ESPP rights to purchase 239,000 ESPP shares and
RSUs for 132,000 shares were outstanding on May 31, 2021 but were not included in the computation of diluted net loss
per share, because the inclusion of such shares would be anti-dilutive.
4. CASH, CASH EQUIVALENTS AND INVESTMENTS
The following table summarizes the Company’s cash, cash equivalents and investments by security type as of May 31,
2023 (in thousands):
Cash
Cash equivalents:
Money market funds
Total cash and cash equivalents
Short-term investments:
U.S. treasury securities
Long-term investments:
Money market funds
Total cash, cash equivalents and
investments
Cost
Gross
Unrealized
Loss
Estimated
Fair Value
$3,182
$ --
$3,182
26,872
$30,054
--
$ --
26,872
$30,054
$17,870
$(17)
$17,853
$150
$ --
$150
$48,074
$(17)
$48,057
The following table summarizes the Company’s cash, cash equivalents and investments by security type as of May 31,
2022 (in thousands):
39
Cash
Cash equivalents:
Money market funds
Total cash and cash equivalents
Long-term investments:
Money market funds
Total cash, cash equivalents and
investments
Cost
Gross
Unrealized
Loss
Estimated
Fair Value
$2,955
$ --
$2,955
28,529
$31,484
--
$ --
28,529
$31,484
$80
$ --
$80
$31,564
$ --
$31,564
Long-term investments are included in other assets on the accompanying consolidated balance sheets.
Unrealized gains and losses on investments classified as available-for-sale are included within accumulated other
comprehensive loss, net of any related tax effect. Upon realization, those amounts are reclassified from accumulated
other comprehensive loss to results of operations.
The unrealized loss of $17,000 as of May 31, 2023 is not considered other-than-temporary, and has been in an
unrealized loss position for less than a year.
5. FAIR VALUE OF FINANCIAL INSTRUMENTS:
The Company’s financial instruments are measured at fair value consistent with authoritative guidance. This
authoritative guidance defines fair value, establishes a framework for using fair value to measure assets and liabilities, and
disclosures required related to fair value measurements.
The guidance establishes a fair value hierarchy based on inputs to valuation techniques that are used to measure fair
value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use
in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect
a reporting entity’s pricing based upon their own market assumptions. The fair value hierarchy consists of the following
three levels:
Level 1 - instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving
identical assets.
Level 2 - instrument valuations are obtained from readily-available pricing sources for comparable instruments.
Level 3 - instrument valuations are obtained without observable market values and require a high level of judgment to
determine the fair value.
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of May
31, 2023 (in thousands):
Money market funds. . . . .
U.S. treasury securities…..
Total. . . . . . . . . . . . . . . .
Balance as of
May 31, 2023
$27,022
17,853
$44,875
Level 1
$27,022
17,853
$44,875
Level 2
$ --
Level 3
$ --
$ --
$ --
The following table summarizes the Company’s financial assets measured at fair value on a recurring basis as of May
31, 2022 (in thousands):
Money market funds. . . . .
Total. . . . . . . . . . . . . . . .
Balance as of
May 31, 2022
$28,609
$28,609
40
Level 1
$28,609
$28,609
Level 2
Level 3
$ --
$ --
$ --
$ --
Included in money market funds as of May 31, 2023 and 2022 was $150,000 and $80,000 of restricted cash,
respectively, representing a security deposit for the Company’s United States manufacturing and office space lease which
is included in other assets in the consolidated balance sheets.
There were no financial liabilities measured at fair value as of May 31, 2023 and 2022.
There were no transfers between Level 1 and Level 2 fair value measurements during the fiscal years ended May 31,
2023 and 2022.
The carrying amounts of financial instruments including cash equivalents, accounts receivables, accounts payable and
certain other accrued liabilities, approximate fair value due to their short maturities.
6. TRADE AND OTHER ACCOUNTS RECEIVABLE, NET:
Accounts receivable comprise (in thousands):
Accounts receivable. . . . . . . . . . . . . . . . . . . .
Less: Allowance for doubtful accounts . . . . .
May 31,
2023
$16,594
--
$16,594
2022
$12,859
--
$12,859
Accounts receivable represents customer trade receivables. As of May 31, 2023 and 2022, there were no allowances
for doubtful accounts.
7. BALANCE SHEET DETAIL:
INVENTORIES:
(In Thousands)
Raw materials and sub-assemblies. . . . . .
Work in process. . . . . . . . . . . . . . . . . . . .
Finished goods. . . . . . . . . . . . . . . . . . . . .
PROPERTY AND EQUIPMENT, NET:
(In Thousands)
Leasehold improvements. . . . . . . . . . . . .
Furniture and fixtures . . . . . . . . . . . . . . .
Machinery and equipment. . . . . . . . . . . .
Test equipment. . . . . . . . . . . . . . . . . . . .
Less: Accumulated depreciation
and amortization. . . . . . . . . . . . . . . . . .
May 31,
2023
$15,953
5,764
2,191
$23,908
2022
$9,507
5,461
83
$15,051
May 31,
2023
$1,310
706
5,445
2,998
10,459
2022
$1,230
697
4,013
2,523
8,463
(7,700)
$2,759
(7,260)
$1,203
Depreciation expense was $450,000, $307,000 and $310,000 for fiscal 2023, 2022, and 2021, respectively.
41
ACCRUED EXPENSES:
(In Thousands)
Commissions and bonuses. . . . . . . . . . . . .
Payroll related. . . . . . . . . . . . . . . . . . . . . . .
Warranty. . . . . . . . . . . . . . . . . . . . . . . . . . .
Professional services. . . . . . . . . . . . . . . . . .
Investor relations . . . . . . . . . . . . . . . . . . . .
Taxes payable . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
$1,728
1,491
267
520
79
22
36
$4,143
May 31,
CUSTOMER DEPOSITS AND DEFERRED REVENUE, SHORT-TERM:
(In Thousands)
Customer deposits. . . . . . . . . . . . . . . . . . . . . . .
Deferred revenue . . . . . . . . . . . . . . . . . . . . . . .
May 31,
2023
$2,690
132
$2,822
2022
$1,505
1,401
410
204
44
13
33
$3,610
2022
$2,263
152
$2,415
8. ACCUMULATED OTHER COMPREHENSIVE LOSS:
Changes in the components of accumulated other comprehensive loss, net of tax, were as follows (in thousands):
Cumulative
Translation
Adjustments
Unrealized Loss
on Investments,
Net
Total
Balance as of May 31, 2021
Other comprehensive loss before reclassifications
Balance as of May 31, 2022
Other comprehensive loss before reclassifications
Balance as of May 31, 2023
$ (28)
(77)
(105)
(33)
$(138)
$--
--
--
(17)
$(17)
$(28)
(77)
(105)
(50)
$(155)
9. INCOME TAXES:
Domestic and foreign components of income (loss) before income tax (expense) benefit are as follows (in thousands):
Domestic. . . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
$ 14,541
76
$ 14,617
Year Ended May 31,
2022
$9,416
125
$9,541
2021
$(13,064)
10,860
$ (2,204)
42
The income tax (expense) benefit consists of the following (in thousands):
Federal income taxes:
Current . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . .
State income taxes:
Current . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . .
Foreign income taxes:
Current . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred . . . . . . . . . . . . . . . . . . . . . . . . .
2023
Year Ended May 31,
2022
$ (28)
--
--
--
$ (59)
--
(5)
--
(32)
--
$ (60)
(27)
--
$ (91)
2021
$163
--
13
--
1
--
$ 177
The Company’s effective tax rate differs from the U.S. federal statutory tax rate, as follows:
U.S. federal statutory tax rate. . . . . . . . . . . . . .
State taxes, net of federal tax effect. . . . . . . . .
Foreign rate differential. . . . . . . . . . . . . . . . . .
Stock-based compensation . . . . . . . . . . . . . . .
Research and development credit . . . . . . . . . .
Change in valuation allowance. . . . . . . . . . . . .
Controlled Foreign Corporation Liquidation. .
PPP Loan. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effective tax rate. . . . . . . . . . . . . . . . . . . . . . .
2023
21.0 %
--
0.7
(9.1)
(2.3)
(9.3)
--
--
(0.6)
0.4%
Year Ended May 31,
2022
21.0 %
0.1
0.3
(11.0)
(1.3)
(4.7)
--
(3.7)
0.4
1.1%
2021
21.0 %
0.6
9.8
(4.7)
4.0
(32.1)
9.8
--
(0.4)
8.0%
The components of the net deferred tax assets and liabilities are as follows (in thousands):
Deferred tax assets:
Net operating losses. . . . . . . . . . . . . . . . .
Lease liability . . . . . . . . . . . . . . . . . . . . .
Credit carryforwards. . . . . . . . . . . . . . . . .
Inventory reserves . . . . . . . . . . . . . . . . . .
Reserves and accruals. . . . . . . . . . . . . . . .
Capitalized research and development. . .
Other. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Less: valuation allowance . . . . . . . . . . . .
Deferred tax liabilities:
Operating lease right-of-use assets. . . . . .
Net deferred tax assets (liabilities). . . . . .
Year Ended May 31,
2023
2022
$11,964
1,335
6,235
938
1,200
1,187
297
(21,859)
1,297
(1,297)
$ --
$14,912
218
5,535
934
1,360
--
220
(22,980)
199
(199)
$ --
The valuation allowance decreased by $1,121,000 during fiscal 2023, decreased by $278,000 during fiscal 2022, and
increased by $2,438,000 during fiscal 2021. As of May 31, 2023 and 2022, the Company provided a full valuation
allowance against the deferred tax assets as it did not have enough objective evidence as required by GAAP to reverse its
full valuation allowance. The Company will continue to evaluate the need for a valuation allowance against its deferred
tax assets on a quarterly basis.
At May 31, 2023 and 2022, the Company has federal net operating loss carryforwards of approximately $46,967,000
and $61,068,000 respectively, to reduce future taxable income. A portion of the federal net operating losses will begin to
expire in 2024. Federal net operating losses of $14,425,000 will carryforward indefinitely and would be subject to an
80% taxable income limitation in the year utilized. At May 31, 2023 and 2022, the Company has state net operating loss
carryforwards of $30,203,000 and $30,043,000, respectively, to reduce future taxable income. The state net operating
loss carryforwards will begin to expire in 2028.
43
At May 31, 2023 and 2022, the Company has federal research and development credit carryforwards of approximately
$2,923,000 and $2,362,000, respectively, to offset future tax liability. The federal credit carryforwards began to expire in
2022. At May 31, 2023 and 2022, the Company has state research and development credit carryforwards of
approximately $6,623,000 and $6,152,000 respectively, to offset future tax liability. The state credit carryforwards are not
subject to expiration. The Company also has alternative minimum tax credit carryforwards of $34,000 for state purposes.
The credits may be used to offset regular tax and do not expire.
Internal Revenue Code of 1986, as amended (“IRC”) Section 382 (“§382”) limits the use of NOL and tax
credit carryforwards in certain situations where changes occur in the stock ownership of a company. In general, if
we experience a greater than 50% aggregate change in ownership over a three-year period, we are subject to an
annual limitation under IRC §382 on the utilization of the Company’s pre-change NOL carryforwards. California
and other states have similar laws. The annual limitation generally is determined by multiplying the value of the
Company’s stock at the time of such ownership change (subject to certain adjustments) by the applicable long-term
exempt rate. Such limitations may result in expiration of a portion of the NOL carryforwards before utilization.
The Company has made no provision for U.S. income taxes on undistributed earnings of certain foreign subsidiaries
because it is the Company’s intention to permanently reinvest such earnings in its foreign subsidiaries. If such earnings
were distributed, the Company would be subject to additional U.S. income tax expense.
The Company maintains liabilities for uncertain tax positions. These liabilities involve considerable judgment and
estimation and are continuously monitored by management based on the best information available. The aggregate
changes in the balance of gross unrecognized tax benefits are as follows (in thousands):
Beginning balance as of May 31, 2020. . . . . . . . . . . . .
Increases related to prior year tax positions. . . . . . . . .
Increases related to current year tax positions. . . . . . .
Balance at May 31, 2021 . . . . . . . . . . . . . . . . . . . . . . .
Increases related to prior year tax positions. . . . . . . .
Increases related to current year tax positions. . . . . . .
Balance at May 31, 2022 . . . . . . . . . . . . . . . . . . . . . . .
Increases related to prior year tax positions. . . . . . . .
Increases related to current year tax positions. . . . . .
Balance at May 31, 2023 . . . . . . . . . . . . . . . . . . . . . . .
$1,852
11
65
1,928
12
78
2,018
90
168
$2,276
As of May 31, 2023 and 2022, the Company has not recorded interest and penalties associated with its
unrecognized tax benefits. The Company’s unrecognized gross tax benefits would not reduce the annual effective tax
rate if recognized because it has recorded a full valuation allowance on its deferred tax assets. The Company
does not foresee any material changes to the gross unrecognized tax benefit within the next twelve months. The
Company’s policy is to recognize interest and penalties in income tax expense.
The Company’s federal and state income tax returns are subject to possible examination by the taxing
authorities until the expiration of the related statutes of limitations on those tax returns. In general, the federal
income tax returns have a three-year statute of limitations, and the state income tax returns have a four-year
statute of limitations. The Company’s foreign income tax returns are also subject to examination by the foreign tax
authorities with the longest statute of limitations period of four-year.
10. LEASES
The Company leases its manufacturing and office space under operating leases. The principal administrative and
production facility is located in Fremont, California, in a 51,289 square foot building. The Company entered into a non-
cancelable operating lease agreement for its United States manufacturing and office facility, which was renewed in
December 2022 and expires in September 2030. The Company leases a 492 square foot sales and support office in
Utting, Germany. The lease, which began on February 1, 1992 and expires on January 31, 2025, contains an automatic
twelve months renewal, at rates to be determined, if no notice is given prior to six months from expiration. The
Company leases a facility in the Philippines located in a 2,713 square foot building in Clark Freeport Zone, Pampanga.
The lease, which began on January 1, 2021 and expires on December 31, 2025, contains an option to renew for another
44
three years at rates stipulated in the contract, notice for renewal is given six months from expiration. Under the lease
agreements, the Company is responsible for payments of utilities, taxes and insurance.
The Company has only operating leases for real estate including corporate offices, warehouse space and certain
equipment. A lease with an initial term of 12 months or less is generally not recorded on the consolidated balance sheets,
unless the arrangement includes an option to purchase the underlying asset, or renew the arrangement that the Company
is reasonably certain to exercise (short-term leases). The Company recognizes lease expense on a straight-line basis over
the lease term for short-term leases that the Company does not record on its balance sheets. The Company’s operating
leases have remaining lease terms of one year to seven years.
The Company determines whether an arrangement is or contains a lease based on the unique facts and circumstances
present at the inception of the arrangement. Operating lease liabilities and their corresponding right-of-use assets are
recorded based on the present value of lease payments over the expected lease term. The interest rate implicit in lease
contracts is typically not readily determinable. As such, the Company utilizes the appropriate incremental borrowing
rate, which is the rate incurred to borrow on a collateralized basis over a similar term at an amount equal to the lease
payments in a similar economic environment. Certain adjustments to the right-of-use asset may be required for items
such as initial direct costs paid or incentives received.
In December 2022, the Company amended its lease agreement to extend the lease term of an existing office facility
located in the United States, which is considered a lease modification not accounted for as a separate contract. The total
commitments, net of tenant incentives expected to be received, under the modified lease are $8.6 million. The modified
lease expires in fiscal 2031 and contains an option to further extend the lease. The lease modification resulted in an
increase in the Company’s operating lease right-of-use assets and operating lease liabilities of $5.9 million each.
The weighted average remaining lease term for the Company’s operating leases was 7.3 years at May 31, 2023 and the
weighted average discount rate was 7.5%.
The Company’s operating lease cost was $923,000, $766,000 and $761,000 for the years ended May 31, 2023, 2022
and 2021, respectively.
The following table presents supplemental cash flow information related to the Company’s operating leases (in
thousands):
Year Ended May 31,
2023
2022
2021
Cash paid for amounts included in the measurement of operating lease liabilities:
Operating cash flows from operating leases
$835
$813
$779
The following table presents the maturities of the Company’s operating lease liabilities as of May 31, 2023 (in
thousands):
Fiscal year
2024
2025
2026
2027
2028
Thereafter
Total future minimum operating lease payments
Less: imputed interest
Present value of operating lease liabilities
11. BORROWING AND FINANCING ARRANGEMENTS:
Operating Leases
$ 608
1,143
1,174
1,195
1,234
3,075
8,429
(2,129)
$6,300
On January 16, 2020, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with Silicon
Valley Bank (“SVB”). Pursuant to the Loan Agreement, the Company may borrow up to (a) the lesser of (i) the
revolving line of $4.0 million or (ii) the amount available under the borrowing base under a revolving line of credit which
is collateralized by all the Company’s assets except intellectual property. The borrowing base is 80% of eligible accounts,
45
as determined by SVB from the Company’s most recent borrowing base statement; provided, however, SVB has the
right to decrease the foregoing percentage in its good faith business judgment to mitigate the impact of certain events or
conditions, which may adversely affect the collateral or its value. Subject to an event of default, the principal amount
outstanding under the revolving line of credit will accrue interest at a floating per annum rate equal to the greater of (a)
the prime rate plus an additional percentage of up to 1%, which additional percentage depends on the Company’s
adjusted quick ratio, and (b) 4.75%. Interest is payable monthly on the last calendar day of each month and the
outstanding principal amount, the unpaid interest and all other obligations are due on the maturity date, which is 364
days from the effective date of January 13, 2020.
On January 14, 2021, the Company entered into the First Amendment to Loan and Security Agreement (the
“Amendment”) with SVB. The Amendment, among other things, extended the Revolving Line Maturity Date to July 14,
2021; provided, however, that if the Company achieved specified operating metrics on a consolidated basis on or prior
to May 31, 2021 the Amended Revolving Line Maturity Date would be extended to January 13, 2022.
On January 11, 2022, the Company entered into the Second Amendment to the Loan and Security Agreement (the
“Second Amendment”) with SVB. The Second Amendment, among other things, (A) increased the available amount of
the line up to the lesser of (i) $10 million or (ii) the available amount under the borrowing base, under a revolving line of
credit, (B) allowed for borrowing up to $3 million of the available balance based upon eligible customer purchase orders,
(C) reduced the interest rate for account advances under the line to the greater of (a) prime rate plus an additional
percentage up to 1.0%, which additional percentage depends on the Company’s adjusted quick ratio, and (b) 3.25%,
reduces the interest rate for purchase order advances under the line to the greater of (a) prime rate plus an additional
percentage up to 1.5%, which additional percentage depends on the Company’s adjusted quick ratio, and (b) 3.75%, and
(D) extended the maturity date to January 13, 2023.
On January 10, 2023, the Company entered into the Third Amendment to the Loan and Security Agreement (the
“Third Amendment”) with SVB. The Third Amendment, among other things, extends the Revolving Line Maturity Date
to January 13, 2024, provided, however, that (i) if the Company submits a fiscal year 2024 plan of record that is generally
acceptable to SVB, and (ii) the minimum net liquidity at the end of November 30, 2023 is at least $20.0 million, the
Amended Revolving Line Maturity Date would be extended to January 13, 2025.
As of May 31, 2023 the Company had not drawn against the credit facility and was in compliance with all covenants
related to obligations to meet reporting requirements. The balance available to borrow under the line as of May 31, 2023
was $8,004,000. There are no financial covenants in the agreement.
12. LONG-TERM DEBT:
On April 23, 2020, the Company obtained a Payroll Protection Program loan (“PPP Loan”) in the aggregate amount
of $1,679,000 from SVB. The PPP Loan was evidenced by a promissory note dated April 23, 2020 (the “Note”) that
matures on April 23, 2022 and bears interest at a rate of 1% per annum, payable monthly commencing on November 23,
2020. The PPP Loan proceeds were used for payroll, health care benefits, rent and utilities.
Under the terms of the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), PPP Loan recipients
can apply for and be granted forgiveness for all or a portion of loans granted under the PPP Loan. On June 12, 2021,
the Company received confirmation from the SVB that on June 4, 2021, the Small Business Administration approved
the Company’s PPP Loan forgiveness application for the entire PPP Loan balance of $1,679,000 and interest totaling
$19,000, and the Company recognized a gain on loan forgiveness of $1,698,000.
13. STOCK-BASED COMPENSATION:
Stock-based compensation expense consists of expenses for stock options, restricted stock units (“RSUs”),
performance RSUs, or PRSUs, restricted shares, performance restricted shares and employee stock purchase plan, or
ESPP, purchase rights. Stock-based compensation expense for stock options and ESPP purchase rights is measured at
each grant date, based on the fair value of the award using the Black-Scholes option valuation model, and is recognized
as expense over the employee’s requisite service period. This model was developed for use in estimating the value of
publicly traded options that have no vesting restrictions and are fully transferable. The Company’s employee stock
options have characteristics significantly different from those of publicly traded options. For RSUs, PRSUs, restricted
shares and performance restricted shares, stock-based compensation expense is based on the fair value of the Company’s
common stock at the grant date, and is recognized as expense over the employee’s requisite service period. All of the
Company’s stock-based compensation is accounted for as equity instruments.
The following table summarizes the stock-based compensation expense for the fiscal years ended May 31, 2023, 2022
and 2021 (in thousands, except per share data):
46
Stock-based compensation in the form of stock options,
RSUs, and ESPP purchase rights, included in:
Cost of sales. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative. . . . . . . . . . . . . . .
Research and development . . . . . . . . . . . . . . . . . . . .
Net effect on net income (loss). . . . . . . . . . . . . . . . .
Effect on earnings (net loss) per share:
Basic. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diluted. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2023
Year Ended May 31,
2022
2021
$ 331
1,711
706
$2,748
$ 234
1,721
968
$2,923
$ 70
816
215
$1,101
$0.10
$0.09
$0.11
$0.11
$0.05
$0.05
As of the years ended May 31, 2023, 2022 and 2021, stock-based compensation totaling $120,000, $83,000 and $0,
respectively, was capitalized as part of inventory.
During fiscal 2023, 2022 and 2021, the Company recorded stock-based compensation related to stock options, RSUs,
PRSUs, performance restricted shares and restricted shares of $1,988,000, $2,071,000 and $993,000, respectively. For
PRSUs and performance restricted shares, the Company evaluates compensation expense quarterly and recognizes
expense for performance-based awards only if it determines it is probable that performance criteria for the awards will
be met.
As of May 31, 2023, the total compensation expense related to unvested stock-based awards under the Company’s
2016 Equity Incentive Plan, but not yet recognized, was $3,102,000 which is net of estimated forfeitures of $8,000. This
expense will be amortized on a straight-line basis over a weighted average period of approximately 2.3 years.
During fiscal 2023, 2022 and 2021, the Company recorded stock-based compensation related to its ESPP of $760,000,
$935,000 and $108,000, respectively.
As of May 31, 2023, the total compensation expense related to purchase rights under the ESPP but not yet recognized
was $715,000. This expense will be amortized on a straight-line basis over a weighted average period of approximately
1.1 years.
Valuation Assumptions
Valuation and Amortization Method. The Company estimates the fair value of stock options granted using the Black-
Scholes option valuation method and a single option award approach. The fair value under the single option approach is
amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.
Expected Term. The Company’s expected term represents the period that the Company’s stock-based awards are
expected to be outstanding and was determined based on historical experience, giving consideration to the contractual
terms of the stock-based awards, vesting schedules and expectations of future employee behavior as evidenced by
changes to the terms of its stock-based awards.
Volatility. Volatility is a measure of the amounts by which a financial variable such as stock price has fluctuated
(historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company uses the historical
volatility for the past five to six years, based on weighted average of the expected term of option grants, to estimate
expected volatility. Volatility for each of the ESPP’s four time periods of six months, twelve months, eighteen months,
and twenty-four months is calculated separately and included in the overall stock-based compensation expense recorded.
Risk-Free Interest Rate. The Company bases the risk-free interest rate used in the Black-Scholes option valuation
method on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with a remaining
term equivalent to the expected term of the stock awards including the ESPP.
Fair Value. The fair values of the Company’s stock options granted to employees in fiscal 2023, 2022 and 2021 were
estimated using the following weighted average assumptions in the Black-Scholes option valuation method:
47
Year Ended May 31,
2023
2022
2021
Expected term (in years) . . . . . . . . . . . . . . . . . . . . . . .
Volatility. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rates. . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average grant date fair value. . . . . . . . . . . . .
5 - 6
86%
3.12%
$6.29
5 - 6
88%
1.50%
$4.01
6
72%
0.44%
$1.12
The fair value of our ESPP purchase rights for the fiscal 2023, 2022 and 2021 was estimated using the following
weighted average assumptions:
Year Ended May 31,
2023
2022
2021
Expected term (in years) . . . . . . . . . . . . . . . . . . . . . . .
Volatility. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rates. . . . . . . . . . . . . . . . . . . . . . . . .
Weighted average grant date fair value. . . . . . . . . . . . .
0.5 – 2.0
91% – 203%
3.97%–4.94%
$13.60
0.5 – 2.0
101% – 272%
0.05%–2.44%
$9.68
0.5 – 2.0
74% – 88%
0.04%–0.17%
$1.03
EQUITY INCENTIVE PLAN:
In October 2006, the Company’s 2006 Equity Incentive Plan was approved by the shareholders, which provides for
granting of incentive stock options, non-statutory stock options, restricted shares, RSUs, stock appreciation rights,
PRSUs, performance restricted shares and other stock or cash awards as the Company’s Board of Directors may
determine.
In October 2016, the Company’s 2016 Equity Incentive Plan was approved by the Company’s shareholders. The
2016 Equity Incentive Plan replaced our 2006 Equity Incentive Plan, which was scheduled to expire in October 2016,
and will continue in effect until 2026. The exercise price of each stock option equals the market value of the Company's
common stock on the date of grant. Options typically vest over four years, subject to the grantee’s continued service
with the Company through the scheduled vesting date, and expire in seven years from the grant date. A total of
4,848,000 shares of common stock have been reserved for issuance under the Company’s 2016 Equity Incentive Plan,
which includes 2,248,000 shares that remained available for issuance under the 2006 Equity Incentive Plan. Full value
awards, which are equity awards other than options, stock appreciation rights or other awards that are based solely on an
increase in value of the shares following the grant date, when granted or forfeited will be counted as two times the
number of shares added or deducted to the remaining available shares for issuance under 2016 Equity Incentive Plan.
See the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on
November 16, 2021 for further information regarding the 2016 Equity Incentive Plan.
The following tables summarize the Company’s stock option and RSU transactions during fiscal 2023, 2022 and 2021
(in thousands):
48
Balance, May 31, 2020. . . . . . . . . . . . . . . .
Options granted. . . . . . . . . . . . . . . . . . .
RSUs granted. . . . . . . . . . . . . . . . . . . . .
RSUs cancelled. . . . . . . . . . . . . . . . . . . .
Shares withheld for taxes and not issued
Options terminated . . . . . . . . . . . . . . . .
Options expired. . . . . . . . . . . . . . . . . . .
Balance, May 31, 2021 . . . . . . . . . . . . . . . .
Additional shares reserved. . . . . . . . . . .
Options granted. . . . . . . . . . . . . . . . . . .
RSUs granted. . . . . . . . . . . . . . . . . . .
RSUs cancelled. . . . . . . . . . . . . . . . . . . .
Shares withheld for taxes and not issued
Options terminated . . . . . . . . . . . . . . . .
Balance, May 31, 2022 . . . . . . . . . . . . . . . .
Options granted. . . . . . . . . . . . . . . . . . .
RSUs granted. . . . . . . . . . . . . . . . . . .
RSUs cancelled. . . . . . . . . . . . . . . . . . . .
Options terminated . . . . . . . . . . . . . . . .
Balance, May 31, 2023 . . . . . . . . . . . . . . . .
Available
Shares
1,416
(297)
(680)
2
18
455
(341)
573
1,414
(303)
(1,044)
20
(30)
105
735
(110)
(674)
60
16
27
The following table summarized the stock option transactions during fiscal 2023, 2022 and 2021 (in thousands, except
per share data):
Balances, May 31, 2020. . . . . . . . . . . . . . .
Options granted. . . . . . . . . . . . . . . . . . .
Options terminated . . . . . . . . . . . . . . . .
Options exercised. . . . . . . . . . . . . . . . . .
Balances, May 31, 2021. . . . . . . . . . . . . . . .
Options granted. . . . . . . . . . . . . . . . . . .
Options terminated . . . . . . . . . . . . . . . .
Options exercised. . . . . . . . . . . . . . . . . .
Outstanding Options
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
$2.17
$102
Number
of
Shares
3,153
297
(455)
(229)
2,766
303
(105)
(1,367)
$1.78
$2.31
$1.54
$2.16
$807
$5.37
$1.59
$2.28
Balances, May 31, 2022. . . . . . . . . . . . . . . .
1,597
$2.70
$9,290
Options granted. . . . . . . . . . . . . . . . . . .
Options terminated . . . . . . . . . . . . . . . .
Options exercised. . . . . . . . . . . . . . . . . .
110
(16)
(730)
$9.06
$5.42
$2.32
Balances, May 31, 2023. . . . . . . . . . . . . . . .
961
$3.67
$28,211
Options fully vested and expected to vest
at May 31, 2023
947
$3.66
$27,796
49
The options outstanding and exercisable at May 31, 2023 were in the following exercise price ranges (in thousands,
except per share data):
Options Outstanding
at May 31, 2023
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Range of
Exercise
Prices
Number
Outstanding
Shares
Options Exercisable
at May 31, 2023
Number
Exercisable
Shares
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Aggregate
Intrinsic
Value
$1.34
$1.64-$1.86
$2.03-$2.40
$2.93
$3.46-$3.93
$8.00-34.00
41
365
185
139
37
194
$1.34-34.00
961
4.39
3.53
2.61
5.12
1.11
5.97
4.02
$1.34
41
$1.72 291
$2.14
175
$2.93 35
$3.93
$9.77
37
41
$3.67
620
4.39
3.45
2.48
5.12
1.11
5.90
3.35
$1.34
$1.70
$2.14
$2.93
$3.93
$10.18
$2.56
$18,895
The total intrinsic values of options exercised were $17,088,000, $12,542,000 and $152,000 during fiscal 2023, 2022
and 2021, respectively. The weighted average contractual life of the options exercisable and expected to be exercisable at
May 31, 2023 was 4.01 years.
Options to purchase 620,000, 1,042,000 and 2,045,000 shares were exercisable at May 31, 2023, 2022 and 2021,
respectively. These exercisable options had weighted average exercise prices of $2.56, $2.22 and $2.26 as of May 31,
2023, 2022 and 2021, respectively.
The following table summarizes RSUs, PRSUs, restricted shares and performance restricted shares granted to
employees and members of the Company’s Board of Directors during fiscal 2023, 2022 and 2021:
Year Ended May 31,
2023
2022
2021
Employees:
Annual RSUs granted
Weighted-average grant-date fair value of annual RSUs
Annual restricted shares granted
Weighted-average grant-date fair value of annual restricted shares
RSUs granted in lieu of cash payment for salary reductions and bonus
Weighted-average grant-date value of RSU in lieu of cash payment
Maximum PRSUs to be vested if all revenue goals are achieved
Maximum Performance restricted shares to be vested if all revenue goals are achieved
Weighted-average grant-date fair value of PRSUs and performance restricted shares
152,000
$8.03
8,000
$8.00
--
--
80,000
24,000
$8.00
120,000
$3.17
--
--
89,000
$2.50
270,000
--
$3.41
161,000
$1.86
--
--
18,000
$2.21
--
--
--
Members of Board of Directors:
RSUs granted
Weighted-average grant-date fair value of RSUs
Maximum PRSUs granted to be vested if all revenue goals are achieved
Weighted-average grant-date fair value of PRSUs
44,000
$11.35
25,000
$8.00
43,000
$8.02
--
--
161,000
$1.81
--
--
PRSUs were granted to key officers and members of Board of Directors based upon revenue target thresholds for
fiscal 2023 and 2022.
50
The following table summarizes the RSUs and PRSUs vested and unvested during fiscal 2023, 2022 and 2021:
Net RSUs and PRSUs vested
Shares withheld to settle payroll taxes
Weighted average grant-date fair value of vested RSUs
and PRSUs
RSUs and PRSUs cancelled
Weighted average grant-date fair value of cancelled RSUs
and PRSUs
RSUs and PRSUs unvested
Weighted average grant-date fair value of unvested RSUs
and PRSUs
Intrinsic value of unvested RSUs and PRSUs
(in thousands)
EMPLOYEE STOCK PURCHASE PLAN:
2023
240,000
178,000
$4.47
30,000
$8.56
345,000
$6.40
$11,392
Year Ended May 31,
2022
96,000
62,000
$3.12
10,000
$2.93
185,000
$3.00
$1,554
2021
207,000
9,000
$1.90
1,000
$3.46
132,000
$1.88
$297
In October 2006, the Company’s shareholders approved the 2006 Employee Stock Purchase Plan. In October 2016,
the Company’s shareholders approved the Company’s Amended and Restated 2006 Employee Stock Purchase Plan (the
“Purchase Plan”), which amended and restated the 2006 Employee Stock Purchase Plan. The Purchase Plan extended
the term of the 2006 Employee Stock Purchase Plan indefinitely. See the Company’s Registration Statements on Form
S-8 filed with the Securities and Exchange Commission on November 18, 2020 and November 16, 2022 for further
information regarding the Purchase Plan. The Purchase Plan has consecutive, overlapping, twenty-four month offering
periods. Each twenty-four-month offering period includes four six-month purchase periods. The offering periods
generally begin on the first trading day on or after April 1 and October 1 each year. All employees who work a
minimum of 20 hours per week and are customarily employed by the Company (or an affiliate thereof) for at least five
months per calendar year are eligible to participate. Under the Purchase Plan, shares are purchased through employee
payroll deductions at exercise prices equal to 85% of the lesser of the fair market value of the Company’s common stock
at either the first day of an offering period or the last day of the purchase period. If a participant’s rights to purchase
stock under all employee stock purchase plans of the Company accrue at a rate which exceeds $25,000 worth of stock
for a calendar year, such participant may not be granted an option to purchase stock under the Purchase Plan. The
maximum number of shares a participant may purchase during a single purchase period is 3,000 shares. In October
2022, the Company’s shareholders approved an amendment to the Purchase Plan to increase the number of shares
authorized for issuance thereunder by an additional 350,000 shares of the Company’s common stock. After such
amendment, a total of 2,550,000 shares of the Company’s common stock have been authorized for issuance under the
Purchase Plan. During the fiscal years ended May 31, 2023, 2022 and 2021, ESPP purchase rights of 77,000, 101,000,
and 279,000 shares, respectively, were granted. For the fiscal years ended May 31, 2023, 2022 and 2021, approximately
211,000, 178,000 and 147,000 shares of common stock, respectively, were issued under the Purchase Plan. As of May
31, 2023, a total of 2,152,000 shares have been issued under the Purchase Plan, and 398,000 ESPP shares remain
available for issuance.
14. EMPLOYEE BENEFIT PLANS:
EMPLOYEE STOCK OWNERSHIP PLAN:
The Company has a non-contributory, trusteed employee stock ownership plan for full-time employees who have
completed three consecutive months of service and for part-time employees who have completed one year of service
and have attained an age of 21. The Company can contribute either shares of the Company’s stock or cash to the plan.
The contribution is determined annually by the Company and cannot exceed 15% of the annual aggregate salaries of
those employees eligible for participation in the plan. On May 31, 2007, the Company converted the Aehr Test Systems
Employee Stock Bonus Plan into the Aehr Test Systems Employee Stock Ownership Plan (the “Plan”). The stock
bonus plan was converted to an employee stock ownership plan (“ESOP”) to enable the Plan to better comply with
changes in the law regarding Company stock. Individuals’ account balances vest at a rate of 20% per year commencing
upon completion of two years of service. Non-vested balances, which are forfeited following termination of
employment, are allocated to the remaining employees in the Plan. Under the Plan provisions, each employee who
reaches age fifty-five (55) and has been a participant in the Plan for ten years will be offered an election each year to
direct the transfer of up to 25% of his/her ESOP account to the employee self-directed account in the Savings and
Retirement Plan. For anyone who met the above prerequisites, the first election to diversify holdings was offered after
May 31, 2008. In the sixth year, employees will be able to diversify up to 50% of their ESOP accounts. Contributions
of $300,000 were authorized for the plan during fiscal 2023, $250,000 for 2022 and $60,000 for 2021. The contribution
amounts are recorded as compensation expense in the period authorized and included in accrued expenses in the period
51
authorized. Contributions of 29,832 shares were made to the ESOP during fiscal 2023 for fiscal 2022. Contributions of
26,666 shares were made to the ESOP during fiscal 2022 for fiscal 2021. Contributions of 36,000 shares were made to
the ESOP during fiscal 2021 for fiscal 2020. The contribution for fiscal 2023 will be made in fiscal 2024. Shares held in
the ESOP are included in the EPS calculation.
401(K) PLAN:
The Company maintains a defined contribution savings plan (the “401(k) Plan”) to provide retirement income to all
qualified employees of the Company. The 401(k) Plan is intended to be qualified under Section 401(k) of the Internal
Revenue Code of 1986, as amended. The 401(k) Plan is funded by voluntary pre-tax contributions from employees.
Contributions are invested, as directed by the participant, in investment funds available under the 401(k) Plan. The
Company is not required to make, and did not make, any contributions to the 401(k) Plan during fiscal 2023, 2022 and
2021.
15. OTHER (EXPENSE) INCOME, NET:
Other (expense) income, net comprises the following (in thousands):
Foreign exchange (loss) gain. . . . . . . . . . . . . . . . . .
Other expense, net . . . . . . . . . . . . . . . . . . . . . . . . .
16. PRODUCT WARRANTIES:
2023
$(3)
--
$(3)
Year Ended May 31,
2022
$32
(2)
$30
2021
$(111)
(51)
$(162)
The Company provides for the estimated cost of product warranties at the time revenues are recognized on the
products shipped. While the Company engages in extensive product quality programs and processes, including actively
monitoring and evaluating the quality of its component suppliers, the Company’s warranty obligation is affected by
product failure rates, material usage and service delivery costs incurred in correcting a product failure. Should actual
product failure rates, material usage or service delivery costs differ from the Company’s estimates, revisions to the
estimated warranty liability would be required.
The standard warranty period is one year for systems and ninety days for parts and service.
Following is a summary of changes in the Company’s liability for product warranties during the fiscal years ended May
31, 2023 and 2022 (in thousands):
Balance at the beginning of the year. . . . . . . . . . . . . . .
Accruals for warranties issued during the year . . . . . . .
Adjustment to previously existing warranty . . . . . . . . .
Consumption of reserves . . . . . . . . . . . . . . . . . . . . . . .
May 31,
2023
2022
$ 410
420
61
(624)
$ 494
465
98
(647)
Balance at the end of the year. . . . . . . . . . . . . . . . . . . .
$ 267
$ 410
The accrued warranty balance is included in accrued expenses on the consolidated balance sheets.
17. SEGMENT INFORMATION:
The Company has only one reportable segment. The information for revenue category by type, product line,
geography and timing of revenue recognition, is summarized in Note 2, “Revenue.”
Property and equipment information is based on the physical location of the assets. The following table presents
property and equipment information for geographic areas (in thousands):
52
United States. . . . . . . . . . . . . . . . . . . . . . .
Asia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Europe. . . . . . . . . . . . . . . . . . . . . . . . . . . .
May 31,
2023
2022
$2,713
44
2
$2,759
$1,156
47
--
$1,203
As of May 31, 2023, operating lease right-of-use assets of $6,007,000, $70,000 and $45,000 were allocated in the
United States, Asia and Europe, respectively. As of May 31, 2022, the operating lease right-of-use assets of $822,000 and
$95,000 were allocated in the United States and Asia, respectively.
There were no revenues through distributors for the fiscal years ended May 31, 2023, 2022 and 2021.
18. DISSOLUTION OF AEHR TEST SYSTEMS JAPAN:
On July 31, 2020, the Company completed the liquidation of ATS-Japan, a majority owned subsidiary. Accordingly,
the Company deconsolidated ATS-Japan and recognized an aggregate net gain of $2,401,000 for the period ended
August 31, 2020. The net gain was mainly due to cumulative translation adjustment reclassified into earnings of
$2,186,000 and the residual income tax effect in connection with the cumulative translation adjustment released into
income tax benefits of $215,000.
19. EQUITY:
On August 25, 2021, the Board of Directors authorized management to take actions necessary for the execution of a
$75 million shelf registration. A Registration Statement on Form S-3 was filed with the SEC on September 3, 2021. A
Prospectus Supplement for an "At the Market" ("ATM") sale of $25 million of common stock was subsequently filed on
September 17, 2021. On October 8, 2021, the Company executed the ATM offering by selling 1,696,729 shares of
common stock at an average selling price of $14.73 per share. The gross proceeds to the Company were $25.0 million,
before commission fees of $0.7 million and offering expenses of $0.3 million. Another Prospectus Supplement for an
ATM sale of $25 million of common stock was subsequently filed on February 8, 2023. The Company partially executed
the ATM offering by selling 208,917 shares of common stock at an average selling price of $34.78 per share. The gross
proceeds to the Company were $7.3 million, before commissions of $0.2 million and offering expenses of $0.2 million.
20. COMMITMENTS AND CONTINGENCIES:
COMMITMENTS
As of May 31, 2023 and 2022, the Company had restricted money market funds of $150,000 and $80,000, respectively,
held by a financial institution, representing a security deposit for its United States manufacturing and office space lease.
This amount is included in other assets on the consolidated balance sheets.
PURCHASE OBLIGATIONS
The Company has purchase obligations to certain suppliers. In some cases, the products the Company purchases are
unique and have provisions against cancellation of the order. At May 31, 2023, the Company had $26,318,000 of
purchase obligations which are due within the following 12 months. This amount does not include contractual
obligations recorded on the consolidated balance sheets as liabilities.
CONTINGENCIES
The Company may, from time to time, be involved in legal proceedings arising in the ordinary course of business.
While there can be no assurances as to the ultimate outcome of any litigation involving the Company, management does
not believe any pending legal proceedings will result in judgment or settlement that will have a material adverse effect on
the Company’s consolidated financial position, results of operations or cash flows.
In the normal course of business to facilitate sales of its products, the Company indemnifies other parties, including
customers, with respect to certain matters, for example, including against losses arising from a breach of representations
or covenants, or from intellectual property infringement or other claims. These agreements may limit the time within
which an indemnification claim can be made and the amount of the claim. In addition, the Company has entered into
indemnification agreements with its officers and directors, and the Company’s bylaws contain similar indemnification
obligations to the Company’s agents.
53
It is not possible to determine the maximum potential amount under these indemnification agreements due to the
limited history of prior indemnification claims and the unique facts and circumstances involved in each particular
agreement. To date, payments made by the Company under these agreements have not had a material impact on the
Company’s operating results, financial position or cash flow.
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A. Controls and Procedures
(a) Evaluation of disclosure controls and procedures.
Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the
effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act, as of the end of the period covered by this Annual Report on Form 10-K. Based on this evaluation, our Chief
Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are
effective to ensure that information we are required to disclose in reports that we file or submit under the Securities
Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities
and Exchange Commission rules and forms, and that such information is accumulated and communicated to
management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow for timely
decisions regarding required disclosure.
(b) Management’s report on internal control over financial reporting.
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as
defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our Chief Executive
Officer and Chief Financial Officer, our management conducted an evaluation of the effectiveness of our internal
control over financial reporting based upon the framework in “Internal Control – Integrated Framework” (2013 Framework)
issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation,
management has concluded that the Company’s internal control over financial reporting was effective as of May 31,
2023.
(c) Changes in internal controls over financial reporting.
There were no changes in our internal controls over financial reporting that occurred during the period covered by
this Annual Report on Form 10-K that have materially affected, or are reasonably likely to materially affect, our internal
controls over financial reporting.
Item 9B. Other Information
On March 28, 2023, Kenneth B. Spink, the Company’s Chief Financial Officer (“CFO”), notified the Company of his
intention to retire after the end of current fiscal year end reporting. The Company has hired Chris Siu as CFO effective
June 1, 2023. To facilitate an orderly transition, Mr. Spink intends to remain at the Company and continue to serve in
his current role until August 31, 2023.
Item 9C. Disclosure Regarding Foreign Jurisdiction that Prevent Inspections
Not applicable.
54
PART III
Item 10. Directors, Executive Officers and Corporate Governance
The information required by this item is incorporated by reference to our Proxy Statement to be filed with the
Securities and Exchange Commission in connection with our 2023 Annual Meeting of Shareholders.
Item 11. Executive Compensation
The information required by this item is incorporated by reference to our Proxy Statement to be filed with the
Securities and Exchange Commission in connection with our 2023 Annual Meeting of Shareholders.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required by this item is incorporated by reference to our Proxy Statement to be filed with the
Securities and Exchange Commission in connection with our 2023 Annual Meeting of Shareholders.
Item 13. Certain Relationships and Related Transactions, and Director Independence
The information required by this item is incorporated by reference to our Proxy Statement to be filed with the
Securities and Exchange Commission in connection with our 2023 Annual Meeting of Shareholders.
Item 14. Principal Accountant Fees and Services
The information required by this item is incorporated by reference to our Proxy Statement to be filed with the
Securities and Exchange Commission in connection with our 2023 Annual Meeting of Shareholders.
55
Item 15. Exhibits and Financial Statement Schedules
(a) The following documents are filed as part of this Report:
PART IV
1. Financial Statements
See Index under Item 8.
2. Financial Statement Schedule
See Index under Item 8.
3. Exhibits
See Item 15(b) below.
(b) Exhibits
The following exhibits are filed as part of or incorporated by reference into this Report:
56
Description
------------------------------------------------------------------------------------------------------------
Restated Articles of Incorporation of Registrant.
Exhibit No.
-----------
3.1(1)
3.2(2)(25)(28) Amended and Restated Bylaws of Registrant.
4.1(3)
4.2(4)
Form of Common Stock certificate.
Registration Rights Agreement by and among the Company and the
Investors (as defined therein), dated as of September 22, 2016.
Description of Securities
2006 Equity Incentive Plan.*
Amended and Restated 2006 Employee Stock Purchase Plan.*
2016 Equity Incentive Plan.*
Form of Indemnification Agreement entered into between Registrant
and its directors and executive officers.*
Form of Change of Control Agreement.*
Lease dated August 3, 1999 for facilities located at Building C,
400 Kato Terrace, Fremont, California.
First Amendment dated May 06, 2008 for facilities located at
400 Kato Terrace, Fremont, California.
Second Amendment dated November 7, 2014 for facilities located at
400 Kato Terrace, Fremont, California.
Third Amendment dated February 27, 2018 for facilities located at
400 Kato Terrace, Fremont, California.
Offer Letter dated January 3, 2012, between the Company and Gayn Erickson.*
Offer Letter dated March 5, 2013, between the Company and Rhea Posedel.*
Change of Control Severance Agreement dated January 3, 2012, between the Company and Gayn
4.3(32)
10.1(5)
10.2(6)
10.3(7)
10.4(8)
10.5(9)
10.6(10)
10.7(11)
10.8(12)
10.9(13)
10.10(14)
10.11(15)
10.12(16)
Erickson.*
10.13(17)
10.15(18)
10.16(19)
10.17(20)
10.18(21)
10.19(22)
Amended and Restated Change of Control Severance Agreement dated March 5, 2013, between the
Company and Rhea J. Posedel.*
Form of 2006 Equity Incentive Plan Stock Option Award Agreement.*
Form of 2006 Equity Incentive Plan Restricted Stock Unit Award.*
Form of 2016 Equity Incentive Plan Stock Option Award Agreement.*
Form of 2016 Equity Incentive Plan Restricted Stock Unit Award.*
Purchase Agreement by and among the Company and the Investors (as defined therein),
dated as of September 22, 2016.
Loan and Security Agreement, dated as of January 13, 2020 and effective on January 16, 2020, by and
10.20(23)
between Silicon Valley Bank and Aehr Test Systems.
10.21(24)
Promissory Note, dated April 23, 2020, with Silicon Valley Bank as Lender and Aehr Test Systems as
Borrower.
10.22(26) First Amendment, dated as of January 14, 2021, to Loan and Security Agreement by and between
10.23(27) Equity Distribution Agreement, dated as of September 17, 2021, by and between Craig-Hallum
Silicon Valley Bank and Aehr Test Systems, dated January 13, 2020
Capital Group LLC and Aehr Test Systems
10.24(29) Second Amendment, dated as of January 11, 2022, to Loan and Security Agreement by and between
Silicon Valley Bank and Aehr Test Systems, dated January 13, 2020
10.25(30) Third Amendment, dated as of January 10, 2023, to Loan and Security Agreement by and between
Silicon Valley Bank and Aehr Test Systems, dated January 17, 2023
31.1
21.1(33)
21.1
23.1
24.1
10.26(31) Equity Distribution Agreement, dated as of February 7, 2023, by and among William Blair &
Company L.L.C., Craig-Hallum Capital Group LLC and Aehr Test Systems
Subsidiaries of the Company.
Subsidiaries of the Company (filed herewith).
Consent of BPM LLP - Independent Registered Public Accounting Firm (filed herewith).
Power of Attorney (incorporated by reference to the signature page of this
Annual Report on Form 10-K).
Certification Statement of Chief Executive Officer pursuant to
Section 302(a) of the Sarbanes-Oxley Act of 2002 (filed herewith).
Certification Statement of Chief Financial Officer pursuant to
Section 302(a) of the Sarbanes-Oxley Act of 2002 (filed herewith).
Certification of Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
XBRL Instance Document
XBRL Taxonomy Extension Schema Document
XBRL Taxonomy Extension Calculation Linkbase Document
101.INS
101.SCH
101.CAL
32.1
31.2
57
XBRL Taxonomy Extension Definition Linkbase Document
XBRL Taxonomy Extension Label Linkbase Document
XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF
101.LAB
101.PRE
------------------------
(1) Incorporated by reference to the same-numbered exhibit previously filed with the Company’s Registration Statement
on Form S-1 filed June 11, 1997 (File No. 333-28987).
(2) Incorporated by reference to the same-numbered exhibit previously filed with the Company’s Current Report on
Form 8-K filed September 11, 2019 (File No. 000-22893).
(3) Incorporated by reference to the same-numbered exhibit previously filed with Amendment No.1 to the Company’s
Registration Statement on Form S-1 filed July 17, 1997 (File No. 333-28987).
(4) Incorporated by reference to Exhibit 10.2 previously filed with the Company’s Current Report on Form 8-K filed
September 28, 2016 (File No. 000-22893).
(5) Incorporated by reference to Exhibit 4.1 previously filed with the Company’s Registration Statement on Form S-8
filed October 27, 2006 (File No. 333-138249).
(6) Incorporated by reference to Exhibit 4.2 previously filed with the Company’s Registration Statement on Form S-8
filed November 14, 2016 (File No. 333-214589).
(7) Incorporated by reference to Appendix A of the Company’s Definitive Proxy Statement filed September 26, 2019
(File No. 333-214589).
(8) Incorporated by reference to Exhibit 10.4 previously filed with Amendment No.1 to the Company’s Registration
Statement on Form S-1 filed July 17, 1997 (File No. 333-28987).
(9) Incorporated by reference to Exhibit 10.14 previously filed with the Company’s Form 10-K for the year ended May
31, 2001 filed August 29, 2001 (File No. 000-22893).
(10) Incorporated by reference to Exhibit 10.12 exhibit previously filed with the Company’s Form 10-K for the year
ended May 31, 1999 filed August 30, 1999 (File No. 000-22893).
(11) Incorporated by reference to Exhibit 10.15 previously filed with the Company’s Current Report on Form 8-K filed
May 9, 2008 (File No. 000-22893).
(12) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
November 12, 2014 (File No. 000-22893).
(13) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
March 2, 2018 (File No. 000-22893).
(14) Incorporated by reference to Exhibit No. 10.1 previously filed with the Company's Current Report on Form 8-K
filed January 9, 2012 (File No. 000-22893).
(15) Incorporated by reference to Exhibit No. 10.1 previously filed with the Company's Current Report on Form 8-K
filed March 8, 2013 (File No. 000-22893).
(16) Incorporated by reference to Exhibit No. 10.3 previously filed with the Company's Current Report on Form 8-K
filed January 9, 2012 (File No. 000-22893).
(17) Incorporated by reference to Exhibit No. 10.2 previously filed with the Company's Current Report on Form 8-K
filed March 8, 2013 (File No. 000-22893).
(18) Incorporated by reference to Exhibit 10.17 previously filed with the Company’s Annual Report on Form 10-K filed
August 29, 2016 (File No. 000-22893).
(19) Incorporated by reference to Exhibit 10.18 previously filed with the Company’s Annual Report on Form 10-K filed
August 29, 2016 (File No. 000-22893).
(20) Incorporated by reference to Exhibit 10.19 previously filed with the Company’s Annual Report on Form 10-K filed
August 29, 2017 (File No. 000-22893).
(21) Incorporated by reference to Exhibit 10.20 previously filed with the Company’s Annual Report on Form 10-K filed
August 29, 2017 (File No. 000-22893).
(22) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
September 28, 2016 (File No. 000-22893).
(23) Incorporated by references to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
January 1, 2020 (File No. 000-22893).
(24) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
April 28, 2020 (File No. 000-22893).
(25) Incorporated by reference to Exhibit 3.1 previously filed with the Company’s Current Report on Form 8-K filed
September 2, 2020 (File No. 000-22893).
(26) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
January 14, 2021 (File No. 000-22893).
(27) Incorporated by reference to Exhibit 1.1 previously filed with the Company’s Current Report on Form 8-K filed
September 17, 2021 (File No. 000-22893).
(28) Incorporated by reference to Exhibit 3.1 previously filed with the Company’s Current Report on Form 8-K filed
October 19, 2021 (File No. 000-22893).
(29) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
January 11, 2022 (File No. 000-22893).
58
(30) Incorporated by reference to Exhibit 10.1 previously filed with the Company’s Current Report on Form 8-K filed
January 17, 2023 (File No. 000-22893).
(31) Incorporated by reference to Exhibit 1.1 previously filed with the Company’s Current Report on Form 8-K filed
February 8, 2023 (File No. 000-22893).
(32) Incorporated by reference to Exhibit 4.3 previously filed with the Company’s Annual Report on Form 10-K filed
August 27, 2021 (File No. 000-22893).
(33) Incorporated by reference to Exhibit 21.1 previously filed with the Company’s Annual Report on Form 10-K filed
August 27, 2021 (File No. 000-22893).
* Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to
participate.
Item 16. Form 10-K Summary
None.
59
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly
caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: August 28, 2023
AEHR TEST SYSTEMS
By: /s/ GAYN ERICKSON
---------------------------------------
Gayn Erickson
PRESIDENT AND CHIEF EXECUTIVE OFFICER
(Principal Executive Officer)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and
appoints Gayn Erickson and Kenneth B. Spink, jointly and severally, his attorneys-in-fact, each with the power of
substitution, for him in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and
to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may
do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1934, this Annual Report on Form 10-K has been signed below
by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
Signature Title Date
-------------------------- ----------------------------------- -----------------
President, Chief Executive
Officer, and Director
/s/ GAYN ERICKSON (Principal Executive Officer) August 28, 2023
-------------------------- -----------------
Gayn Erickson Vice President of Finance
and Chief Financial Officer
/s/ KENNETH B. SPINK (Principal Financial and August 28, 2023
-------------------------- Accounting Officer) -----------------
Kenneth B. Spink
/s/ FARIBA DANESH Director August 28, 2023
-------------------------- -----------------
Fariba Danesh
/s/ LAURA OLIPHANT Director August 28, 2023
-------------------------- -----------------
Laura Oliphant
/s/ RHEA J. POSEDEL Chairman August 28, 2023
-------------------------- -----------------
Rhea J. Posedel
/s/ GEOFFREY G. SCOTT Director August 28, 2023
-------------------------- -----------------
Geoffrey G. Scott
/s/ HOWARD T. SLAYEN Director August 28, 2023
-------------------------- -----------------
Howard T. Slayen
60
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-
259317, 333-216792, 333-214218 and 333-204008) and the Registration Statements on Form S-8 (No. 333-268413, 333-
261147, 333-250175, 333-235105, 333-228509, 333-214589, 333-208130, 333-200442, 333-184865, 333-177954, 333-
163100, 333-155389, 333-138249, 333-119636, 333-52592 and 333-40577) of Aehr Test Systems of our report dated
August 28, 2023 relating to the consolidated financial statements, which appears in this Form 10-K.
Exhibit 23.1
/s/ BPM LLP
San Jose, California
August 28, 2023
61
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT
I, Gayn Erickson, certify that:
1. I have reviewed this annual report on Form 10-K of Aehr Test Systems;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors
(or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report
financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant’s internal control over financial reporting.
Date: August 28, 2023
/s/ GAYN ERICKSON
-----------------------------------------------
Gayn Erickson
President and Chief Executive Officer
(Principal Executive Officer)
62
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT
I, Kenneth B. Spink, certify that:
1. I have reviewed this annual report on Form 10-K of Aehr Test Systems;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during
the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors
(or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report
financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in
the registrant’s internal control over financial reporting.
Date: August 28, 2023
/s/ KENNETH B. SPINK
--------------------------------------------------------------------
Kenneth B. Spink
Vice President of Finance and Chief Financial Officer
(Principal Financial and Accounting Officer)
63
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Gayn Erickson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Annual Report of Aehr Test Systems on Form 10-K for the period ending May 31,
2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial
condition and results of operations of Aehr Test Systems.
Date: August 28, 2023
By:
/s/ GAYN ERICKSON
----------------------------------------------------------------
Gayn Erickson
President and Chief Executive Officer
(Principal Executive Officer)
I, Kenneth B. Spink, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that the Annual Report of Aehr Test Systems on Form 10-K for the period ending May 31,
2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that
information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial
condition and results of operations of Aehr Test Systems.
Date: August 28, 2023
(Principal Financial and Accounting Officer)
By:
/s/ KENNETH B. SPINK
-----------------------------------------------------------------
Kenneth B. Spink
Vice President of Finance and Chief Financial Officer
The foregoing certifications are not deemed filed with the Securities and Exchange Commission for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), and are not to be incorporated by
reference into any filing of Aehr Test Systems under the Securities Act of 1933, as amended, or the Exchange Act,
whether made before or after the date hereof, regardless of any general incorporation language in such filing.
64
DIRECTORS Rhea J. Posedel(3) Chairman Gayn Erickson President Chief Executive Officer Fariba Danesh(2) Chief Operating Officer PsiQuantum Laura Oliphant (1) (2) (3) Independent consultant and investor Geoffrey G. Scott (1) (3) Private Investor Howard T. Slayen (1) (2) Retired Partner PricewaterhouseCoopers (1) Member of the Audit Committee (2) Member of the Compensation Committee (3) Member of the Corporate Governance and Nominating Committee OFFICERS Gayn Erickson President Chief Executive Officer Chris P. Siu Executive Vice President of Finance Chief Financial Officer and Secretary Adil Engineer Chief Operating Officer David S. Hendrickson Chief Technology Officer Donald P. Richmond II Vice President of Engineering Vernon Rogers Executive V.P. of Sales and Marketing Alistar N. Sporck V.P. of Contactor Business Unit CORPORATE HEADQUARTERS 400 Kato Terrace Fremont, CA 94539 Telephone: 510.623.9400 Fax: 510.623.9450 Website: www.aehr.com SUBSIDIARIES Aehr Test Systems Philippines Inc. Bldg. 10 Berthaphil II South Industrial Park, Manunggal Street, Clark Freeport Zone, Pampanga, 2023 Philippines Telephone: 63.454994671 Email: atsphsupport@aehr.com Aehr Test Systems GmbH Industriestrasse 9 D-86919 Utting Germany Telephone: 49.8806.2021 Fax: 49.8806.2024 Email: atsg@aehr.com SHAREHOLDER INFORMATION Legal Counsel Latham & Watkins, LLP Menlo Park, CA Independent Registered Public Accounting Firm BPM LLP San Jose, CA Transfer Agent and Registrar Computershare Trust Company, N.A. P. O. Box 43078 Providence, RI 02940-3078 Toll free: 800.962.4284 (US, Canada, Puerto Rico) 781.575.3100 (non-US) Investor Relations MKR Group, Inc. Telephone: 323.468.2300 Email: aehr@mkr-group.com Annual Meeting The annual meeting of shareholders will be held at 4:00 p.m. on October 23, 2023 at the Company’s Corporate Headquarters. CORPORATE INFORMATION Aehr Test Systems’ corporate headquarters has been certified to the International Standards Organization (ISO) 9001 standard since 1997. CORPORATE HEADQUARTERS
400 KATO TERRACE
FREMONT, CA 94539
TELEPHONE: 510.623.9400
FAX: 510.623.9450
WEB: WWW.AEHR.COM